{"content":"<li class=\"n-box-item date-title\" data-end=\"1557547199\" data-start=\"1557460800\" data-txt=\"Monday, December 23, 2019\">Friday, May 10, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3462760\" data-ts=\"1557525018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462760-weatherford-misses-0_34-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford misses by $0.34, revenue in-line</a></h4><ul><li>Weatherford (NYSE:<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International plc'>WFT</a>): Q1 GAAP EPS of -$0.48 <font color=\"red\">misses by $0.34</font>.</li><li>Revenue of $1.35B (-4.9% Y/Y) in-line.</li><li>Shares <font color=\"red\">-30%</font> AH.</li><li><a href=\"https://seekingalpha.com/filing/4485690\" target=\"_blank\">10-Q</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3462760\" data-linked=\"Weatherford misses by $0.34, revenue in-line\" data-tweet=\"$WFT $WFTIQ - Weatherford misses by $0.34, revenue in-line https://seekingalpha.com/news/3462760-weatherford-misses-0_34-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3462760-weatherford-misses-0_34-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462759\" data-ts=\"1557524771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462759-novavax-adjusts-convertible-rate-after-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax adjusts convertible rate after reverse split</a></h4><ul>   <li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) has <a href=\"https://seekingalpha.com/pr/17508737-novavax-announces-adjustment-conversion-rate-3_75-percent-convertible-senior-notes-due-2023\" target=\"_blank\">adjusted the conversion rate</a> applicable to its 3.75% convertible senior notes due 2023, a move related to a reverse stock split that took effect today.</li>    <li>The company this week announced a 1-for-20 reverse stock split, a move approved by shareholders on Wednesday. That allowed Novavax to satisfy minimum price requirements for listing on Nasdaq Global Select.</li>    <li>As a result of that, the conversion rate on the notes will now be 7.3411 shares of common stock per $1,000 principal amount of the notes.</li>    <li>Shares are <font color=\"red\">2.6% lower</font> aftermarket, following a <font color=\"red\">drop of 8.6%</font> during the regular session today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462759\" data-linked=\"Novavax adjusts convertible rate after reverse split\" data-tweet=\"$NVAX - Novavax adjusts convertible rate after reverse split https://seekingalpha.com/news/3462759-novavax-adjusts-convertible-rate-after-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3462759-novavax-adjusts-convertible-rate-after-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462755\" data-ts=\"1557524171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462755-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/VIOT' title='Viomi Technology Co., Ltd'>VIOT</a> <font color=\"green\">+1.3%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/LONE' title='Lonestar Resources US Inc.'>LONE</a> <font color=\"red\">-16.2%</font>. <a href='https://seekingalpha.com/symbol/CINR' title='Ciner Resources LP'>CINR</a> <font color=\"red\">-13.0%</font>. <a href='https://seekingalpha.com/symbol/YCBD' title='cbdMD, Inc.'>YCBD</a> <font color=\"red\">-11.9%</font><a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a> <font color=\"red\">-5.3%</font>. <a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a> <font color=\"red\">-4.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462755\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$VIOT $LONE $CINR - After Hours Gainers / Losers https://seekingalpha.com/news/3462755-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462755-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462740\" data-ts=\"1557521680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTD\" target=\"_blank\">FTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462740-ftdplus-6_5-key-shareholder-plans-to-approach-management\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTD +6.5% as key shareholder plans to approach management</a></h4><ul>   <li>FTD Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a>) is <font color=\"green\">up 6.5%</font> after hours following an <a href=\"https://seekingalpha.com/filing/4485067\" target=\"_blank\">SEC filing</a> by shareholder Nantahala Capital Management that suggests a new activist stance and points to plans to talk with company principals.</li>    <li>Nantahala has switched its filing to a 13D from a previous 13G, and discloses a slightly higher 14% stake.</li>    <li>It plans to engage with management and the board \"regarding means to enhance shareholder value, including potential strategic alternatives, operational improvements, and changes in personnel. Strategic alternatives could include the sale of the company, the recapitalization of the company, or other transactions.\"</li>    <li>FTD also <font color=\"green\">gained 3.8%</font> during the regular session today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462740\" data-linked=\"FTD +6.5% as key shareholder plans to approach management\" data-tweet=\"$FTD - FTD +6.5% as key shareholder plans to approach management https://seekingalpha.com/news/3462740-ftdplus-6_5-key-shareholder-plans-to-approach-management?source=tweet\" data-url=\"https://seekingalpha.com/news/3462740-ftdplus-6_5-key-shareholder-plans-to-approach-management\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462731\" data-ts=\"1557520671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462731-avonminus-2_5-natura-denies-report-of-2_1b-acquisition-loan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon -2.5% as Natura denies report of $2.1B acquisition loan</a></h4><ul>   <li>Avon (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) is <font color=\"red\">2.5% lower</font> after hours as a potential suitor denied a report that it had an approved loan to buy the company.</li>    <li>Avon <font color=\"green\">moved up 10.7%</font> during the regular session following a <a href=\"https://intereconomia.com/mercados/bolsa/el-banco-santander-aprueba-un-aval-financiero-de-2-100-millones-para-la-opa-de-natura-sobre-avon-20190510-1134/\" target=\"_blank\">report</a> in Intereconomia.com that Brazil's Natura Cosmeticos had gotten approval from Santander to borrow up to $2.1B for an acquisition.</li>    <li>But Natura has denied that, Bloomberg reports.</li>    <li>That $2.1B figure implies a healthy 50% premium to pre-rumor pricing for Avon shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462731\" data-linked=\"Avon -2.5% as Natura denies report of $2.1B acquisition loan\" data-tweet=\"$AVP - Avon -2.5% as Natura denies report of $2.1B acquisition loan https://seekingalpha.com/news/3462731-avonminus-2_5-natura-denies-report-of-2_1b-acquisition-loan?source=tweet\" data-url=\"https://seekingalpha.com/news/3462731-avonminus-2_5-natura-denies-report-of-2_1b-acquisition-loan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462721\" data-ts=\"1557520211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462721-weekly-etf-gainers-losers-05-10-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (05/10/19)</a></h4><ul>     <li><b>Top gainers: </b><a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color=\"green\">+25.1%</font>. <a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a> <font color=\"green\">+22.2%</font>. <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a> <font color=\"green\">+20.5%</font>. <a href='https://seekingalpha.com/symbol/UVXY' title='ProShares Ultra VIX Short-Term Futures ETF'>UVXY</a> <font color=\"green\">+20.1%</font>. <a href='https://seekingalpha.com/symbol/FNGD' title='BMO REX MicroSectors FANG+ Index -3X Inverse Leveraged ETN'>FNGD</a> <font color=\"green\">+19.1%</font> .</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/YINN' title='Direxion Daily FTSE China Bull 3x Shares ETF'>YINN</a><font color=\"red\"> -19.3%</font>. <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a> <font color=\"red\">-17.7%</font>. <a href='https://seekingalpha.com/symbol/KORU' title='Direxion Daily South Korea Bull 3x Shares ETF'>KORU</a><font color=\"red\"> -17.6%</font>. <a href='https://seekingalpha.com/symbol/FNGU' title='BMO REX MicroSector FANG+ Index 3X Leveraged ETN'>FNGU</a> <font color=\"red\">-16.8%</font>. <a href='https://seekingalpha.com/symbol/INDL' title='Direxion Daily India 3x Bull Shares ETF'>INDL</a> <font color=\"red\">-16.2%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462721\" data-linked=\"Weekly ETF Gainers / Losers (05/10/19)\" data-tweet=\"$TVIX $YANG $SOXS - Weekly ETF Gainers / Losers (05/10/19) https://seekingalpha.com/news/3462721-weekly-etf-gainers-losers-05-10-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3462721-weekly-etf-gainers-losers-05-10-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462705\" data-ts=\"1557519020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBER\" target=\"_blank\">UBER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462705-uber-closesminus-7_6-on-first-day-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber closes -7.6% on first day trading</a></h4><ul><li>Uber (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) closes its first day of trading<font color=\"red\"> down 7.6% </font>to $41.57.</li><li>Shares opened at $42, below the $45/share pricing that came on the low end of the $44 to $50 range.</li><li>Competitor Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) closed <font color=\"red\">down 7.4%</font> to $51.09, and GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>) was <font color=\"red\">down 2.6%</font> to $66.60.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462634-uber-opens-ipo-price\" target=\"_blank\">Uber opens below IPO price</a> (May 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462653-grubhub-minus-3_8-percent-uber-goes-public\" target=\"_blank\">GrubHub -3.8% as Uber goes public</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462705\" data-linked=\"Uber closes -7.6% on first day trading\" data-tweet=\"$UBER $UBER $LYFT - Uber closes -7.6% on first day trading https://seekingalpha.com/news/3462705-uber-closesminus-7_6-on-first-day-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3462705-uber-closesminus-7_6-on-first-day-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>210&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462694\" data-ts=\"1557517544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462694-stocks-pull-green-trump-tweets-on-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks pull into the green as Trump tweets more on trade</a></h4><ul><li>Late in the session, all three major U.S. stock averages moved into the green, then took a move down after President Trump issued another pair of tweets on China trade.</li><li>The S&amp;P 500 rises 0.2%, Nasdaq slips 0.1%, and the Dow gains 0.3%.</li><li>Essentially, Trump says U.S.-China trade talks are \"<a href=\"https://twitter.com/realDonaldTrump/status/1126928408934535168\" target=\"_blank\">candid and constructive</a>,\" he has a strong relationship with Chinese leader Xi Jinping, and tariffs on Chinese goods<a href=\"https://twitter.com/realDonaldTrump/status/1126928410310266880\" target=\"_blank\"> may or may not </a>be removed depending on what happens with the talks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462694\" data-linked=\"Stocks pull into the green as Trump tweets more on trade\" data-tweet=\"Stocks pull into the green as Trump tweets more on trade https://seekingalpha.com/news/3462694-stocks-pull-green-trump-tweets-on-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3462694-stocks-pull-green-trump-tweets-on-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462690\" data-ts=\"1557514933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462690-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers: </strong>Cardlytics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDLX' title='Cardlytics, Inc.'>CDLX</a>) <font color=\"green\">+26%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"green\">+19%</font>. Creative Realities (NASDAQ:<a href='https://seekingalpha.com/symbol/CREX' title='Creative Realities, Inc.'>CREX</a>) <font color=\"green\">+14%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+13%</font>. Synchronoss Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Perceptron (NASDAQ:<a href='https://seekingalpha.com/symbol/PRCP' title='Perceptron, Inc.'>PRCP</a>) <font color=\"red\">-23%</font>. inTEST Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/INTT' title='inTEST Corporation'>INTT</a>) <font color=\"red\">-19%</font>. Marin Software Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software Incorporated'>MRIN</a>) <font color=\"red\">-18%</font>. ShotSpotter (NASDAQ:<a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter, Inc.'>SSTI</a>) <font color=\"red\">-18%</font>. Forescout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>) <font color=\"red\">-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462690\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$CDLX $AWSM $CREX - Microcaps dominate tech movers https://seekingalpha.com/news/3462690-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462690-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462687\" data-ts=\"1557514404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLTH\" target=\"_blank\">HLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462687-nobilis-health-chief-makes-quick-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nobilis Health chief makes quick exit</a></h4><ul><li>James Springfield resigned on May 7, and is no longer with the company, says Nobilis Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a>) in a filing today. Springfield was named CEO only last December.</li><li>Shares are <font color=\"red\">down 11.1%</font> to $0.185.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462687\" data-linked=\"Nobilis Health chief makes quick exit\" data-tweet=\"$HLTH - Nobilis Health chief makes quick exit https://seekingalpha.com/news/3462687-nobilis-health-chief-makes-quick-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3462687-nobilis-health-chief-makes-quick-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462685\" data-ts=\"1557512569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462685-meredithminus-7_9-cuts-ebitda-forecast-in-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meredith -7.9% as it cuts EBITDA forecast in Q3 beat</a></h4><ul>   <li>Meredith (NYSE:<a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a>) is <font color=\"red\">7.9% lower</font> today after a Q3 report where it topped highest revenue estimates but also trimmed guidance for underlying earnings for the full year.</li>    <li>Revenues from continuing operations rose 14% (with ad-related and consumer-related revenues up in double digits), and operating earnings swung to a gain of $28M from a loss of $95M (the prior-year period reflected $128M in after-tax special items).</li>    <li>On a comparable basis, earnings from continuing operations were up 29% to $43M, and EBITDA grew 43% to $160M.</li>    <li>It's narrowed its forecast for full-year revenue, to $3.12B-$3.16B from an original $3B-$3.2B. It still expects $550M in net annual cost synergies from the Time acquisition by the end of fiscal 2020, but has modified the time frame.</li>    <li>And it's cut its full-year EBITDA expectations to $700M-$710M from an original $720M-$750M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462514-meredith-beats-0_75-beats-revenue\" target=\"_blank\">Meredith beats by $0.75, beats on revenue</a> (May. 10 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17508177-meredith-reports-fiscal-2019-third-quarter-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462685\" data-linked=\"Meredith -7.9% as it cuts EBITDA forecast in Q3 beat\" data-tweet=\"$MDP - Meredith -7.9% as it cuts EBITDA forecast in Q3 beat https://seekingalpha.com/news/3462685-meredithminus-7_9-cuts-ebitda-forecast-in-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3462685-meredithminus-7_9-cuts-ebitda-forecast-in-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462678\" data-ts=\"1557511202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462678-buckeye-partners-and-calumet-specialty-products-partners-among-energy-materials-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckeye Partners and Calumet Specialty Products Partners among Energy/Materials gainers;  Halcon Resources and Hecla Mining among losers</a></h4><ul><li><b>Gainers: </b>Buckeye Partners (NYSE:<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners, L.P.'>BPL</a>) <font color=\"green\">+28%</font>. Calumet Specialty Products Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a>) <font color=\"green\">+11%</font>. Basic Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>) <font color=\"green\">+10%</font>. NuStar Energy (NYSE:<a href='https://seekingalpha.com/symbol/NS' title='NuStar Energy L.P.'>NS</a>) <font color=\"green\">+7%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Halcon Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcón Resources Corporation'>HK</a>) <font color=\"red\">-43%</font>. Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a>) <font color=\"red\">-11%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services Corp.'>PES</a>) <font color=\"red\">-8%</font>. VAALCO Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color=\"red\">-7%</font>. Ranger Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/RNGR' title='Ranger Energy Services, Inc.'>RNGR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462678\" data-linked=\"Buckeye Partners and Calumet Specialty Products Partners among Energy/Materials gainers;  Halcon Resources and Hecla Mining among losers\" data-tweet=\"$BPL $CLMT $BAS - Buckeye Partners and Calumet Specialty Products Partners among Energy/Materials gainers; Halcon Resources and Hecla Mining among losers https://seekingalpha.com/news/3462678-buckeye-partners-and-calumet-specialty-products-partners-among-energy-materials-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462678-buckeye-partners-and-calumet-specialty-products-partners-among-energy-materials-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462677\" data-ts=\"1557511059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVU\" target=\"_blank\">CVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462677-cpi-aerostructuresplus-4-post-q1-earnings-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CPI Aerostructures +4% post Q1 earnings beats</a></h4><div><ul><li>CPI Aerostructures (<a href='https://seekingalpha.com/symbol/CVU' title='CPI Aerostructures, Inc.'>CVU</a> <font color=\"green\">+4.2%</font>) reports Q1 revenue growth of 40.6% Y/Y to $25.58M, driven by the increase in production rate of Next Generation Jammer Pod program for Raytheon and revenue from WMI subsidiary.</li><li>Q1 Gross margin <font color=\"red\">decline by 109 bps</font> to 21.2%; and operating margin <font color=\"red\">declined by 80 bps</font> to 10.2%.</li><li>SG&amp;A expenses were $2.81M (+36.9% Y/Y); and as percentage of revenue 10.9% down by 30 bps.</li><li>Book-to-bill ratio of 2.0; and consolidated shipping backlog of $134M (+14% Y/Y).</li><li>Total backlog was at $452.9M,as of March 31, 2019 with multi-year defense contracts comprising 84%.</li><li>Cash flow from operations was negative $2.3M compared to negative $2.6M a year ago.</li><li><strong>FY19 Outlook:</strong> Revenue $98M to $102M; pre-tax income $11M to $11.3M; Cash flow from operations in excess of $35M; and effective tax rate of 20%-22%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462418-cpi-aerostructures-beats-0_01-beats-revenue\" target=\"_blank\">CPI Aerostructures beats by $0.01, beats on revenue</a> (May 10)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3462677\" data-linked=\"CPI Aerostructures +4% post Q1 earnings beats\" data-tweet=\"$CVU - CPI Aerostructures +4% post Q1 earnings beats https://seekingalpha.com/news/3462677-cpi-aerostructuresplus-4-post-q1-earnings-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3462677-cpi-aerostructuresplus-4-post-q1-earnings-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462674\" data-ts=\"1557510646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462674-scrippsminus-8_8-q1-loss-worse-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps -8.8% as Q1 loss worse than expected</a></h4><ul>   <li>E.W. Scripps (NASDAQ:<a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a>) is <font color=\"red\">8.8% lower</font> after its Q1 earnings missed Street expectations despite higher retrans revenue than expected.</li>    <li>Revenues grew 15% ($38M) with the help of acquisitions of Triton (which contributed $10.5M) and Raycom stations ($5.6M).</li>    <li>Operating expenses grew with the acquisitions, but the company swung to operating income of $140,000 vs. a year-ago loss of $628,000.</li>    <li>And accounting for interest and pension plan expense, it logged a net loss of $6.8M (narrower than last year's $12.1M loss).</li>    <li>Cash and equivalents were $14.4M as of March 31, vs. total debt of $696M.</li>    <li>It's guiding to local media revenue (pro forma) of $245M-$250M (down low single digits), and national media revenue in the low to mid-$90M range.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462487-e-w-scripps-misses-0_02-beats-revenue\" target=\"_blank\">E.W. Scripps misses by $0.02, beats on revenue</a> (May. 10 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17508121-scripps-reports-first-quarter-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462674\" data-linked=\"Scripps -8.8% as Q1 loss worse than expected\" data-tweet=\"$SSP - Scripps -8.8% as Q1 loss worse than expected https://seekingalpha.com/news/3462674-scrippsminus-8_8-q1-loss-worse-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3462674-scrippsminus-8_8-q1-loss-worse-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462671\" data-ts=\"1557510183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCI\" target=\"_blank\">IPCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462671-fda-oks-intellipharmaceutics-generic-desvenlafaxine-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Intellipharmaceutics&#39; generic desvenlafaxine; shares up 4%</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17508597-intellipharmaceutics-announces-fda-approval-generic-pristiq-r\" target=\"_blank\">approved </a>Intellipharmaceutics' (<a href='https://seekingalpha.com/symbol/IPCI' title='Intellipharmaceutics International Inc.'>IPCI</a> <font color=\"green\">+4%</font>) generic version of Pfizer's antidepressant <a href=\"https://www.pristiq.com/\" target=\"_blank\">Pristiq </a>(desvenlafaxine) in both 50 mg and 100 mg strengths.</li><li>Per Symphony Health Solutions, the U.S. market is ~$268M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462671\" data-linked=\"FDA OKs Intellipharmaceutics&#39; generic desvenlafaxine; shares up 4%\" data-tweet=\"$IPCI $IPCIF - FDA OKs Intellipharmaceutics&#39; generic desvenlafaxine; shares up 4% https://seekingalpha.com/news/3462671-fda-oks-intellipharmaceutics-generic-desvenlafaxine-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3462671-fda-oks-intellipharmaceutics-generic-desvenlafaxine-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462667\" data-ts=\"1557509370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JMIA\" target=\"_blank\">JMIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462667-citron-keeps-up-pressure-on-jumia-shares-down-another-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron keeps up pressure on Jumia - shares down another 27%</a></h4><ul><li>\"Nothing more to say,\" tweets Andrew Left of Jumia Technologies (NYSE:<a href='https://seekingalpha.com/symbol/JMIA' title='Jumia Technologies AG'>JMIA</a>). \"FRAUD. Target 0.\"</li><li>The \"Amazon of Africa\" is <font color=\"red\">down another 27%</font> today, and now <font color=\"red\">off about 40%</font> over the last two sessions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3461916-citron-takes-aim-jumia-technologies-shares-tumble-13-percent\" target=\"_blank\">Citron takes aim at Jumia Technologies; shares tumble 13%</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462667\" data-linked=\"Citron keeps up pressure on Jumia - shares down another 27%\" data-tweet=\"$JMIA - Citron keeps up pressure on Jumia - shares down another 27% https://seekingalpha.com/news/3462667-citron-keeps-up-pressure-on-jumia-shares-down-another-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3462667-citron-keeps-up-pressure-on-jumia-shares-down-another-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462659\" data-ts=\"1557508038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AP\" target=\"_blank\">AP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462659-ampco-pittsburghplus-10-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampco-Pittsburgh +10% post Q1 results</a></h4><ul><li>Ampco-Pittsburgh (<a href='https://seekingalpha.com/symbol/AP' title='Ampco-Pittsburgh Corporation'>AP</a> <font color=\"green\">+10.4%</font>) reported Q1 sales from continuing operations of $107.5M (+1% Y/Y), led by higher sales of air handling units and centrifugal pumps.</li><li>Forged and Cast Engineered Products segment sales from continuing operations were flat; and Operating results from continuing operations declined principally due to the Impairment Charge.</li><li>Air and Liquid Processing segment sales increased ~5% Y/Y; and Operating results were flat.</li><li>Reported operating loss of $11.96M, compared to $1.78M a year ago.</li><li>Adj. operating income was $1.25M; and margin <font color=\"green\">improved by 66 bps</font> to 1.2%.</li><li>Company also announced plan to sell its Avonmore, PA cast roll manufacturing facility to an affiliate of WHEMCO, Inc. The transaction is expected to close in the second half of 2019. The annualized impact on operating results is currently expected to improve income from continuing operations by ~$9M to $10M.</li><li>Recorded impairment charges of $10.1M, in connection with the anticipated divestiture.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462513-ampco-pittsburgh-reports-q1-results\" target=\"_blank\">Ampco-Pittsburgh reports Q1 results</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462659\" data-linked=\"Ampco-Pittsburgh +10% post Q1 results\" data-tweet=\"$AP - Ampco-Pittsburgh +10% post Q1 results https://seekingalpha.com/news/3462659-ampco-pittsburghplus-10-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3462659-ampco-pittsburghplus-10-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462660\" data-ts=\"1557507960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462660-fanhua-among-financial-gainers-ambac-financial-group-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fanhua among financial gainers; Ambac Financial Group leads losers</a></h4><ul><li><b>Gainers:</b> Encore Capital Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ECPG' title='Encore Capital Group, Inc.'>ECPG</a>) <font color=\"green\">+8%</font>. Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">+5%</font>. eXp World Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPI' title='eXp World Holdings, Inc.'>EXPI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Ambac Financial Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBC' title='Ambac Financial Group, Inc.'>AMBC</a>) <font color=\"red\">-9%</font>. The RMR Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RMR' title='The RMR Group Inc.'>RMR</a>) <font color=\"red\">-6%</font>. Third Point Reinsurance (NYSE:<a href='https://seekingalpha.com/symbol/TPRE' title='Third Point Reinsurance Ltd.'>TPRE</a>) <font color=\"red\">-6%</font>. MBIA (NYSE:<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a>) <font color=\"red\">-6%</font>. Five Point Holdings (NYSE:<a href='https://seekingalpha.com/symbol/FPH' title='Five Point Holdings, LLC'>FPH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462660\" data-linked=\"Fanhua among financial gainers; Ambac Financial Group leads losers\" data-tweet=\"$ECPG $FANH $EXPI - Fanhua among financial gainers; Ambac Financial Group leads losers https://seekingalpha.com/news/3462660-fanhua-among-financial-gainers-ambac-financial-group-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462660-fanhua-among-financial-gainers-ambac-financial-group-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462657\" data-ts=\"1557507755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462657-hydrogenics-and-u-s-concrete-among-industrial-gainers-aqua-metals-and-lightpath-technologies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hydrogenics and U.S. Concrete among industrial gainers; Aqua Metals and LightPath Technologies among losers</a></h4><ul><li><b>Gainers: </b>Ampco-Pittsburgh (NYSE:<a href='https://seekingalpha.com/symbol/AP' title='Ampco-Pittsburgh Corporation'>AP</a>) <font color=\"green\">+10%</font>. Hydrogenics (NASDAQ:<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a>) <font color=\"green\">+8%</font>. Construction Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/ROAD' title='Construction Partners, Inc.'>ROAD</a>) <font color=\"green\">+8%</font>. The LGL Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/LGL' title='The LGL Group, Inc.'>LGL</a>) <font color=\"green\">+6%</font>. U.S. Concrete (NASDAQ:<a href='https://seekingalpha.com/symbol/USCR' title='U.S. Concrete, Inc.'>USCR</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>American Electric Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc'>AETI</a>) <font color=\"red\">-24%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-19%</font>. LightPath Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a>) <font color=\"red\">-15%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-10%</font>. ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462657\" data-linked=\"Hydrogenics and U.S. Concrete among industrial gainers; Aqua Metals and LightPath Technologies among losers\" data-tweet=\"$AP $HYGS $ROAD - Hydrogenics and U.S. Concrete among industrial gainers; Aqua Metals and LightPath Technologies among losers https://seekingalpha.com/news/3462657-hydrogenics-and-u-s-concrete-among-industrial-gainers-aqua-metals-and-lightpath-technologies?source=tweet\" data-url=\"https://seekingalpha.com/news/3462657-hydrogenics-and-u-s-concrete-among-industrial-gainers-aqua-metals-and-lightpath-technologies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462653\" data-ts=\"1557507275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462653-grubhubminus-3_8-uber-goes-public\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub -3.8% as Uber goes public</a></h4><ul><li>GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>) <font color=\"red\">drops 3.8%</font> to $65.60 as rival Uber goes public, starting the day lower than its IPO price.</li><li>The Uber Eats delivery service competes with GRUB and private companies DoorDash (<a href='https://seekingalpha.com/symbol/DOORD' title='DoorDash'>DOORD</a>) and Postmates (<a href='https://seekingalpha.com/symbol/POSTM' title='Postmates'>POSTM</a>), to name a few.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462634-uber-opens-ipo-price\" target=\"_blank\">Uber opens below IPO price</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462653\" data-linked=\"GrubHub -3.8% as Uber goes public\" data-tweet=\"$GRUB $GRUB $DOORD - GrubHub -3.8% as Uber goes public https://seekingalpha.com/news/3462653-grubhubminus-3_8-uber-goes-public?source=tweet\" data-url=\"https://seekingalpha.com/news/3462653-grubhubminus-3_8-uber-goes-public\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462651\" data-ts=\"1557506998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAXR\" target=\"_blank\">MAXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462651-mda-wins-canada-deal-for-search-and-rescue-repeaters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MDA wins Canada deal for search and rescue repeaters</a></h4><ul>   <li>MDA (<a href=\"http://seekingalpha.com/symbol/MAXR\" target=\"_blank\">MAXR</a> <font color=\"red\">-4.9%</font>) has won a contract with Canada's government to <a href=\"https://seekingalpha.com/pr/17508555-mda-awarded-canadian-government-contract-deliver-search-rescue-repeaters-satellites\" target=\"_blank\">deliver search and rescue repeaters</a> for satellites.</li>    <li>The contract has an initial value of C$39M, though options would increase that in excess of C$55M.</li>    <li>MDA will initially develop and make 10 flight-ready Search and Rescue/Global Positioning System repeaters to launch on GPS III satellites. The deal has options for an additional 12 flight model repeaters.</li>    <li>Once operational, the equipment is expected to increase speed and location accuracy for locating emergency beacons.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462280-maxar-minus-1_9-percent-slower-revenues-drive-net-loss\" target=\"_blank\">Maxar -1.9% as slower revenues drive net loss</a> (May. 09 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462651\" data-linked=\"MDA wins Canada deal for search and rescue repeaters\" data-tweet=\"$MAXR - MDA wins Canada deal for search and rescue repeaters https://seekingalpha.com/news/3462651-mda-wins-canada-deal-for-search-and-rescue-repeaters?source=tweet\" data-url=\"https://seekingalpha.com/news/3462651-mda-wins-canada-deal-for-search-and-rescue-repeaters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462650\" data-ts=\"1557506749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462650-bpl-gh-pbyi-and-jmia-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BPL, GH, PBYI and JMIA among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Charles &amp; Colvard (NASDAQ:<a href='https://seekingalpha.com/symbol/CTHR' title='Charles & Colvard, Ltd.'>CTHR</a>) <font color=\"green\">+34%</font>. Buckeye Partners (NYSE:<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners, L.P.'>BPL</a>) <font color=\"green\">+28%</font>. Cardlytics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDLX' title='Cardlytics, Inc.'>CDLX</a>) <font color=\"green\">+26%</font>. G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics, Inc.'>GTHX</a>) <font color=\"green\">+24%</font>. Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"green\">+21%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"green\">+22%</font>. Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) <font color=\"green\">+21%</font>. ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+21%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"green\">+19%</font>. Natera (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a>) <font color=\"green\">+17%</font>.</li> <li><strong>Losers: </strong>Halcon Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcón Resources Corporation'>HK</a>) <font color=\"red\">-44%</font>. TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"red\">-38%</font>. Puma Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color=\"red\">-37%</font>. Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"red\">-34%</font>. Qurate Retail (NASDAQ:<a href='https://seekingalpha.com/symbol/QRTEA' title='Qurate Retail, Inc.'>QRTEA</a>) <font color=\"red\">-31%</font>. Pro-Dex (NASDAQ:<a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a>) <font color=\"red\">-29%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-26%</font>. Perceptron (NASDAQ:<a href='https://seekingalpha.com/symbol/PRCP' title='Perceptron, Inc.'>PRCP</a>) <font color=\"red\">-24%</font>. American Electric Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc'>AETI</a>) <font color=\"red\">-24%</font>. Jumia Technologies AG (NYSE:<a href='https://seekingalpha.com/symbol/JMIA' title='Jumia Technologies AG'>JMIA</a>) <font color=\"red\">-24%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462650\" data-linked=\"BPL, GH, PBYI and JMIA among notable midday movers\" data-tweet=\"$CTHR $BPL $CDLX - BPL, GH, PBYI and JMIA among notable midday movers https://seekingalpha.com/news/3462650-bpl-gh-pbyi-and-jmia-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462650-bpl-gh-pbyi-and-jmia-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462647\" data-ts=\"1557506360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALRM\" target=\"_blank\">ALRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462647-tariffs-weight-on-alarm-com-results-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tariffs weight on Alarm.com results - Stifel</a></h4><ul><li>Stifel says the threat of tariffs kept Alarm.com (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRM' title='Alarm.com Holdings, Inc.'>ALRM</a>) from raising its profit outlook for the year because about a third of ALRM's hardware products are imported from China.</li><li>Analyst Brad Reback says Alarm's costs could increase if the company doesn't pass the extra expenses on to customers.</li><li>Stifel remains on the ALRM sidelines but raises the PT from $45 to $53, which stays the Street-low target.</li><li>ALRM shares are <font color=\"red\">down 9%</font> Y/Y to $63.42.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462508-alarm-com-beats-q1-guides-upside-revenue\" target=\"_blank\">Alarm.com beats Q1, guides upside revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462647\" data-linked=\"Tariffs weight on Alarm.com results - Stifel\" data-tweet=\"$ALRM - Tariffs weight on Alarm.com results - Stifel https://seekingalpha.com/news/3462647-tariffs-weight-on-alarm-com-results-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3462647-tariffs-weight-on-alarm-com-results-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462646\" data-ts=\"1557506237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462646-stocks-bounce-from-morning-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks bounce from morning lows</a></h4><ul><li>Stocks trim their losses, as utilities (<font color=\"green\">+0.2%</font>) and materials (<font color=\"green\">+0.2%</font>) sectors join real estate (<font color=\"green\">+0.5%</font>) in positive territory.</li><li>Nasdaq<font color=\"red\"> falls 0.9%</font> after falling as much as 1.9%; S&amp;P 500, <font color=\"red\">down </font>0.6%, had sank as much as 1.6%; and the Dow, <font color=\"red\">down 0.6%</font>, compares with its earlier low of -1.4%.</li><li>Health care (<font color=\"red\">-1.2%</font>) and information technology (<font color=\"red\">-1.2%</font>) are the market's biggest laggards.</li><li>The 10-year Treasury yield levels out to 2.445%, after touching 2.429% earlier.</li><li>Crude oil revives, <font color=\"green\">rising 0.4%</font> to $61.96 per barrel.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462621-apple-leads-averages-sharply-lower\" target=\"_blank\">Apple leads averages sharply lower</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462646\" data-linked=\"Stocks bounce from morning lows\" data-tweet=\"Stocks bounce from morning lows https://seekingalpha.com/news/3462646-stocks-bounce-from-morning-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3462646-stocks-bounce-from-morning-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462635\" data-ts=\"1557504321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSTR\" target=\"_blank\">FSTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462635-l-b-foster-rallies-11_3-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">L.B. Foster rallies 11.3% post Q1 results</a></h4><ul><li>L.B. Foster (<a href='https://seekingalpha.com/symbol/FSTR' title='L.B. Foster Company'>FSTR</a> <font color=\"green\">+11.3%</font>) reports <a href=\"https://seekingalpha.com/pr/17507337-l-b-foster-reports-first-quarter-operating-results\" target=\"_blank\">Q1</a> revenue growth by 22.9% Y/Y to $150.5M.</li><li>Rail Products and Services sales increased by 21.8% Y/Y, Construction Products sales increased by 29.2% Y/Y and Tubular and Energy Services sales increased by 19.3% Y/Y.</li><li>Gross margin <font color=\"green\">increased 130 bps</font> to 19.4%, was favorably impacted by a <font color=\"green\">510 and 90 bps improvement</font> within Tubular and Construction segments, respectively.</li><li>New orders were $180.3M (+2.5% Y/Y), driven primarily by strong activity within the Tubular segment and, to a lesser extent, Rail segment.</li><li>Backlog increased by 13.5% Y/Y to $250.1M.</li><li>Net cash provided by operating activities for Q1 totaled $13.5M.</li><li>There was a increase in outstanding debt of $15.2M from December 31, 2018 to $90.2M.</li><li>\u201cCapex were $1.8M above prior year levels due to the attractive growth and productivity projects underway in the current year.\u201d said Bob Bauer, President and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462152-l-b-foster-beats-0_22-beats-revenue\" target=\"_blank\">L.B. Foster beats by $0.22, beats on revenue</a> (May. 09 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462635\" data-linked=\"L.B. Foster rallies 11.3% post Q1 results\" data-tweet=\"$FSTR - L.B. Foster rallies 11.3% post Q1 results https://seekingalpha.com/news/3462635-l-b-foster-rallies-11_3-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3462635-l-b-foster-rallies-11_3-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462632\" data-ts=\"1557504098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAD\" target=\"_blank\">ROAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462632-construction-partners-up-8-on-q2-results-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Construction Partners up 8% on Q2 results beats</a></h4><ul><li>Construction Partners (<a href='https://seekingalpha.com/symbol/ROAD' title='Construction Partners, Inc.'>ROAD</a> <font color=\"green\">+8%</font>) reports Q2 revenue increase of 38.2% Y/Y to $164.3M, due to favorable working conditions.</li><li>Q2 Gross margin <font color=\"green\">improved by 50 bps</font> to 12.1%; and operating margin <font color=\"red\">fell by 1,004 bps</font> to 3.5%.</li><li>Q2 Adj. EBITDA increased by 74.2% Y/Y to $13.97M, and margin <font color=\"green\">improved by 176 bps</font> to 8.5%.</li><li>Net cash provided by operating activities in the quarter was $5.3M, compared to $28.12M a year ago.</li><li>During the quarter company grew construction project backlog to $584.8M, at March 31, 2019.</li><li><strong>FY19 Outlook:</strong> Revenue $790M to $810M; Net income of $40.75M to $44M; and Adj. EBITDA $88.5M to $92.5M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462144-construction-partners-beats-0_02-beats-revenue\" target=\"_blank\">Construction Partners beats by $0.02, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462632\" data-linked=\"Construction Partners up 8% on Q2 results beats\" data-tweet=\"$ROAD - Construction Partners up 8% on Q2 results beats https://seekingalpha.com/news/3462632-construction-partners-up-8-on-q2-results-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3462632-construction-partners-up-8-on-q2-results-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462636\" data-ts=\"1557504040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462636-westport-fuel-systems-leads-consumer-gainers-jakks-pacific-and-iconix-brand-group-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel Systems leads consumer gainers; JAKKS Pacific and Iconix Brand Group among losers</a></h4><ul><li><b>Gainers: </b>Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"green\">+27%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"green\">+14%</font>. Vista Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor Inc.'>VSTO</a>) <font color=\"green\">+11%</font>. Koss (NASDAQ:<a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a>) <font color=\"green\">+10%</font>. Superior Industries International (NYSE:<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>JAKKS Pacific (NASDAQ:<a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a>) <font color=\"red\">-19%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"red\">-18%</font>. Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color=\"red\">-9%</font>. IT Tech Packaging (NYSEMKT:<a href='https://seekingalpha.com/symbol/ITP' title='IT Tech Packaging, Inc.'>ITP</a>) <font color=\"red\">-8%</font>. Callaway Golf (NYSE:<a href='https://seekingalpha.com/symbol/ELY' title='Callaway Golf Company'>ELY</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462636\" data-linked=\"Westport Fuel Systems leads consumer gainers; JAKKS Pacific and Iconix Brand Group among losers\" data-tweet=\"$WPRT $VFF $VSTO - Westport Fuel Systems leads consumer gainers; JAKKS Pacific and Iconix Brand Group among losers https://seekingalpha.com/news/3462636-westport-fuel-systems-leads-consumer-gainers-jakks-pacific-and-iconix-brand-group-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3462636-westport-fuel-systems-leads-consumer-gainers-jakks-pacific-and-iconix-brand-group-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462634\" data-ts=\"1557503873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBER\" target=\"_blank\">UBER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462634-uber-opens-below-ipo-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber opens below IPO price</a></h4><ul><li>Uber (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) opens its first day of trading at $42 after pricing towards the low end of its $44 to $50 range.</li><li>Competitor Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) is <font color=\"red\">down 6.3%</font> to $51.72.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462264-uber-prices-ipo-low-end-wsj\" target=\"_blank\">Uber prices IPO at low end - WSJ</a> (May 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462596-uber-bid-slipping\" target=\"_blank\">The Uber bid is slipping</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462634\" data-linked=\"Uber opens below IPO price\" data-tweet=\"$UBER $LYFT - Uber opens below IPO price https://seekingalpha.com/news/3462634-uber-opens-below-ipo-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3462634-uber-opens-below-ipo-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>173&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462631\" data-ts=\"1557503418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XNCR\" target=\"_blank\">XNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462631-xencor-up-5-on-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xencor up 5% on Q1 beat</a></h4><ul><li>Thinly traded Xencor (<a href='https://seekingalpha.com/symbol/XNCR' title='Xencor, Inc.'>XNCR</a> <font color=\"green\">+5.2%</font>) is up on 20% higher volume, albeit on turnover of only 269K shares, following its <a href=\"https://seekingalpha.com/pr/17507294-xencor-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1 report</a> released after the close yesterday.</li><li>Revenue: $111.9M from collaboration and license agreement with Genentech.</li><li>Net income: $81.4M; EPS: $1.38.</li><li><strong>Key future milestones</strong>:</li><li>Resume enrollment in Phase 1 study of XmAb14045.</li><li>Data readouts from Phase 1 studies of XmAb13676 and XmAb18087 in H2.</li><li>Launch Phase 1 study of XmAb22841, combined with Merck's Keytruda (pembrolizumab), in solid tumors later this quarter.</li><li>Announce preliminary data from Phase 1 study of XmAb20717 in solid tumors in H2.</li><li>Submit IND for XmAb24306 in H2.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3461995-xencor-beats-1_79-beats-revenue\" target=\"_blank\">Xencor beats by $1.79, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462631\" data-linked=\"Xencor up 5% on Q1 beat\" data-tweet=\"$XNCR - Xencor up 5% on Q1 beat https://seekingalpha.com/news/3462631-xencor-up-5-on-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3462631-xencor-up-5-on-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462627\" data-ts=\"1557502817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGT\" target=\"_blank\">RLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462627-radiant-logistics-slides-7_2-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radiant Logistics slides 7.2% post Q3 results</a></h4><ul><li>Radiant Logistics (<a href='https://seekingalpha.com/symbol/RLGT' title='Radiant Logistics, Inc.'>RLGT</a> <font color=\"red\">-7.2%</font>) reported <a href=\"https://seekingalpha.com/pr/17507289-radiant-logistics-announces-results-third-fiscal-quarter-ended-march-31-2019\" target=\"_blank\">Q3</a> revenue growth of 1% Y/Y to $206.05M, and net revenue of $52.7M (+8% Y/Y).</li><li>U.S. revenues $179.1M (+1.1% Y/Y); and net revenue of $45.4M (+6.8% Y/Y), where Transportation net revenues were $44.2M (+6.3% Y/Y) and Value added services net revenues were $1.1M (+22.2% Y/Y).</li><li>Canada revenues $27.1M (+0.4% Y/Y); and net revenue of $7.4M (+21.3% Y/Y), where Transportation net revenues were $5.1M (+4.8% Y/Y) and Value added services net revenues were $1.1M (+57.9% Y/Y).</li><li>Q3 Net revenue margin <font color=\"green\">increased by 180 bps</font> to 25.6%; and operating margin <font color=\"green\">increased 159 bps</font> to 2.3%.</li><li>Adj. EBITDA margin <font color=\"green\">increased by 420 bps</font> to 16% (expressed as a function of net revenue).</li><li>The business also continues to deliver strong cashflows generating $17.1M in cash from operations from the 3 months ended March 31, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462052-radiant-logistics-beats-0_04-misses-revenue\" target=\"_blank\">Radiant Logistics beats by $0.04, misses on revenue</a> (May. 09 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462627\" data-linked=\"Radiant Logistics slides 7.2% post Q3 results\" data-tweet=\"$RLGT - Radiant Logistics slides 7.2% post Q3 results https://seekingalpha.com/news/3462627-radiant-logistics-slides-7_2-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3462627-radiant-logistics-slides-7_2-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462629\" data-ts=\"1557502760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462629-westport-fuel-soars-after-tailwinds-pick-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel soars after tailwinds pick up</a></h4><ul> <li>Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) is showing off a <font color=\"green\">23.5% gain</font> after the company's Q1 earnings report showed a lot of promise to investors.</li> <li>Westport management said macroeconomic factors and a stricter emissions regulation environment are both working in its favor.</li> <li>During the conference call (<a href=\"https://seekingalpha.com/article/4262405-westport-fuel-systems-inc-wprt-ceo-david-johnson-q1-2019-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), CEO David Johnson seemed to also take a subtle shot at competitors. \"The transportation sector is on the cusp of a dynamic change. It's important not to confuse tradeshow announcements around prototypes and demonstrations with production solutions like ours that can be purchased and put to use right now,\" he stated.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462134-westport-plus-5-percent-ebitda-gain\" target=\"_blank\">Westport +5% after EBITDA gain</a> (May 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462629\" data-linked=\"Westport Fuel soars after tailwinds pick up\" data-tweet=\"$WPRT - Westport Fuel soars after tailwinds pick up https://seekingalpha.com/news/3462629-westport-fuel-soars-after-tailwinds-pick-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3462629-westport-fuel-soars-after-tailwinds-pick-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462625\" data-ts=\"1557502071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTW\" target=\"_blank\">MTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462625-manitowoc-slips-10-despite-q1-earnings-beats-raises-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manitowoc slips 10% despite Q1 earnings beats; raises FY19 guidance</a></h4><ul><li>Manitowoc (<a href='https://seekingalpha.com/symbol/MTW' title='The Manitowoc Company, Inc.'>MTW</a> <font color=\"red\">-10.4%</font>) reports Q1 revenues of $418M an increase of 8.3% Y/Y, reflecting higher crane shipments in the Americas and EURAF regions, coupled with favorable price realization.</li><li>Q1 Gross margin <font color=\"green\">expanded by 147 bps</font> to 19.2%; and operating margin <font color=\"green\">expanded by 344 bps</font> to 3.9%.</li><li>Q1 Adj. EBITDA increased by 73.1% Y/Y to $29.6M; and margin <font color=\"green\">improved by 265 bps</font> to 7.1%. Driven by organic growth in the North American market, favorable mix, global price initiatives and cost reductions realized through restructuring initiatives.</li><li>Net cash used for operating activities in the quarter was $267.3M, compared to $168.4M a year ago.</li><li>Backlog was $693.6M (-8.3% Y/Y), as of March 31, 2019.</li><li>Company <a href=\"https://seekingalpha.com/pr/17503269-manitowoc-company-announces-30-million-share-repurchase-program\" target=\"_blank\">authorized</a> a share repurchase program of up to $30M of the Company\u2019s common stock with no stated expiration.</li><li><strong>FY19 Guidance, raised:</strong> Revenue $1.9B to $1.975B (prior $1.85B to $1.95B); Adj. EBITDA $130M to $140M (prior $125 to $145M); and Capex of ~$35M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462024-manitowoc-beats-0_10-beats-revenue\" target=\"_blank\">Manitowoc beats by $0.10, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462625\" data-linked=\"Manitowoc slips 10% despite Q1 earnings beats; raises FY19 guidance\" data-tweet=\"$MTW - Manitowoc slips 10% despite Q1 earnings beats; raises FY19 guidance https://seekingalpha.com/news/3462625-manitowoc-slips-10-despite-q1-earnings-beats-raises-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3462625-manitowoc-slips-10-despite-q1-earnings-beats-raises-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462623\" data-ts=\"1557501707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462623-beyond-meat-rally-takes-breather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat rally takes a breather</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) finally cools off with a <font color=\"red\">6.0% decline</font> today on heavy volume.</li> <li>Is it a coincidence that some profit taking on the red-hot IPO stock arrives on the same day as the Uber public debut?</li><li>Beyond Meat is trading at $63.88 vs. the $25 IPO pricing level</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3462623\" data-linked=\"Beyond Meat rally takes a breather\" data-tweet=\"$BYND - Beyond Meat rally takes a breather https://seekingalpha.com/news/3462623-beyond-meat-rally-takes-breather?source=tweet\" data-url=\"https://seekingalpha.com/news/3462623-beyond-meat-rally-takes-breather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462621\" data-ts=\"1557501503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462621-apple-leads-averages-sharply-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple leads averages sharply lower</a></h4><ul><li>A bit more than 90 minutes after the open, the major averages have slid to session lows, the S&amp;P 500 <font color=\"red\">down 1.3%</font> and the Nasdaq <font color=\"red\">down 1.6%</font>.</li><li>Leading the way down is a <font color=\"red\">3% decline</font> in Apple, with Morgan Stanley's Katy Huberty <a href=\"https://seekingalpha.com/news/3462539-tariffs-slash-apple-eps-morgan-stanley\" target=\"_blank\">suggesting Chinese tariffs</a> could cause a 23% decline in the company's earnings in 2020</li><li>Uber, meanwhile, is indicated to open where the IPO priced - at $45 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462621\" data-linked=\"Apple leads averages sharply lower\" data-tweet=\"Apple leads averages sharply lower https://seekingalpha.com/news/3462621-apple-leads-averages-sharply-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3462621-apple-leads-averages-sharply-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462619\" data-ts=\"1557500585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462619-nomura-trims-estimates-on-wynn-after-tough-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura trims estimates on Wynn after tough quarter</a></h4><ul> <li>Nomura updates on Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-6.4%</font>) after the casino operator's disappointing earnings report.</li> <li>ANalyst Harry Curtis estimates Wynn lost ~50 bps of sequential gross gaming revenue share in the quarter. \"The de-emphasis of second tier junkets at Wynn Macau (Peninsula), which really began in 4Q, was likely responsible for much of WYNN\u2019s share loss in the quarter,\" he notes.</li> <li>Wynn's EBITDA out of Las Vegas was impacted by a 2.1% decline in RevPAR and 25% decline in table drop, according to Curtis.</li> <li>Nomura keeps a Buy rating on Wynn, but lowers 2019-2020 EBITDA estimates and takes its price target to $142 from $146.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3461983-wynn-resorts-beats-0_03-misses-revenue\" target=\"_blank\">Wynn Resorts beats by $0.03, misses on revenue</a> (May 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462171-wynn-minus-4-percent-operating-revenue-trails-estimates\" target=\"_blank\">Wynn -4% after operating revenue trails estimates</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462619\" data-linked=\"Nomura trims estimates on Wynn after tough quarter\" data-tweet=\"$WYNN - Nomura trims estimates on Wynn after tough quarter https://seekingalpha.com/news/3462619-nomura-trims-estimates-on-wynn-after-tough-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3462619-nomura-trims-estimates-on-wynn-after-tough-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462618\" data-ts=\"1557500551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462618-evofem-biosciences-and-g1-therapeutics-among-healthcare-gainers-transenterix-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evofem Biosciences and G1 Therapeutics among healthcare gainers; TransEnterix leads the losers</a></h4><ul><li><b>Gainers: </b>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics, Inc.'>GTHX</a>) <font color=\"green\">+28%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"green\">+21%</font>. MorphoSys (NASDAQ:<a href='https://seekingalpha.com/symbol/MOR' title='MorphoSys AG'>MOR</a>) <font color=\"green\">+17%</font>. Avedro (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDR' title='Avedro, Inc.'>AVDR</a>) <font color=\"green\">+16%</font>. Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) <font color=\"green\">+15%</font>.</li><li><b>Losers: </b>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"red\">-37%</font>. Puma Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color=\"red\">-37%</font>. Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"red\">-34%</font>. Pro-Dex (NASDAQ:<a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a>) <font color=\"red\">-28%</font>. FibroGen (NASDAQ:<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen, Inc.'>FGEN</a>) <font color=\"red\">-24%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462618\" data-linked=\"Evofem Biosciences and G1 Therapeutics among healthcare gainers; TransEnterix leads the losers\" data-tweet=\"$GTHX $EVFM $MOR - Evofem Biosciences and G1 Therapeutics among healthcare gainers; TransEnterix leads the losers https://seekingalpha.com/news/3462618-evofem-biosciences-and-g1-therapeutics-among-healthcare-gainers-transenterix-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462618-evofem-biosciences-and-g1-therapeutics-among-healthcare-gainers-transenterix-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462616\" data-ts=\"1557500489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDEX\" target=\"_blank\">PDEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462616-pro-dex-down-28-after-fq3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pro-Dex down 28% after FQ3 beat</a></h4><ul><li>Investors are behaving as if they were expecting more from Pro-Dex (<a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a> <font color=\"red\">-28.4%</font>) in its <a href=\"https://seekingalpha.com/pr/17507487-pro-dex-inc-announces-fiscal-2019-third-quarter-nine-month-results\" target=\"_blank\">fiscal third quarter</a>. Shares are down on triple normal volume, albeit on turnover of only 86.5K shares.</li><li>Sales were up 25% to $6.9M, ahead of consensus of $6.1M.</li><li>EPS was $0.17, up 55% and above consensus of $0.13.</li><li>On the working capital front, cash and equivalents and investments totaled ~$12.5M at the end of March. Cash flow ops for the first three quarters was $3.1M, up 72% from a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462260-pro-dex-beats-0_04-beats-revenue\" target=\"_blank\">Pro-Dex beats by $0.04, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462616\" data-linked=\"Pro-Dex down 28% after FQ3 beat\" data-tweet=\"$PDEX - Pro-Dex down 28% after FQ3 beat https://seekingalpha.com/news/3462616-pro-dex-down-28-after-fq3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3462616-pro-dex-down-28-after-fq3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462608\" data-ts=\"1557499689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNBR\" target=\"_blank\">NNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462608-nnplus-6-post-q1-earnings-beats-reaffirms-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NN +6% post Q1 earnings beats; reaffirms FY19 guidance</a></h4><div><ul><li>NN (<a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a> <font color=\"green\">+6.3%</font>) reports Q1 net sales growth of 26.1% to $213.25M, driven by $55.2M from acquisitions.</li><li>Q1 Operating margin <font color=\"red\">declined by 190 bps</font> to 0.3%, and Adj. operating margin<font color=\"green\"> improved by 30 bps</font> to 10.8%.</li><li>Adj. EBITDA was $34.5M (+20.8% Y/Y); and margin <font color=\"green\">improved by 70 bps</font> to 16.9%.</li><li>Life Sciences nets sales were $86M (+175.6% Y/Y); and adj. income from operations $17.2M compared to $6.9M a year ago.</li><li>Mobile Solutions net sales were $78.1M (-13% Y/Y); and adj. operating income of $6.4M compared to $11M a year ago. Impacted by continued headwinds in the global automotive market.</li><li>Power Solutions net sales were $49.7M (+2% Y/Y); and adj. Operating income $8.4M compared to $9.2M a year ago.</li><li>Q1 Free cash flow of negative $16.8M.</li><li><strong>2Q19 Guidance:</strong> Sales $215M to $222M; and Adj. EBITDA $35M to $40M.</li><li><strong>FY19 Guidance, reaffirmed:</strong> Sales $870M to $890M; Adj. operating margin 12.4% to 13%; Adj. EBITDA $166M to $174M; Adj. EPS $1.10 to $1.30; and FCF $40M to $50M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462261-nn-beats-0_05-beats-revenue\" target=\"_blank\">NN beats by $0.05, beats on revenue</a> (May 9)</li><li><a href=\"https://seekingalpha.com/article/4262482-nn-inc-2019-q1-results-earnings-call-slides\" target=\"_blank\">Slides</a></li></ul></div><div class=\"tiny-share-widget\" data-id=\"3462608\" data-linked=\"NN +6% post Q1 earnings beats; reaffirms FY19 guidance\" data-tweet=\"$NNBR - NN +6% post Q1 earnings beats; reaffirms FY19 guidance https://seekingalpha.com/news/3462608-nnplus-6-post-q1-earnings-beats-reaffirms-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3462608-nnplus-6-post-q1-earnings-beats-reaffirms-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462609\" data-ts=\"1557499646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462609-oppenheimer-confident-on-gopro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer confident on GoPro</a></h4><ul> <li>Oppenheimer weighs in on GoPro's (<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a> <font color='red'>-0.4%</font>) beat and raise earnings report.</li> <li>The firm says strong product traction, effective channel management and improved marketing led to the strong results.</li> <li>\"GoPro has achieved an impressive turnaround since last year and its management demonstrated solid execution and ability to adapt to new market trends and consumer demands,\" writes analyst Andrew Uerkwitz.</li><li>Oppenheimer has an Outperform rating and 12-month to 18-month price target of $9.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462002-gopro-beats-0_02-beats-revenue\" target=\"_blank\">GoPro beats by $0.02, beats on revenue</a> (May 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462054-gopro-minus-2-percent-light-ebitda\" target=\"_blank\">GoPro -2% after light EBITDA</a> (May 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462609\" data-linked=\"Oppenheimer confident on GoPro\" data-tweet=\"$GPRO - Oppenheimer confident on GoPro https://seekingalpha.com/news/3462609-oppenheimer-confident-on-gopro?source=tweet\" data-url=\"https://seekingalpha.com/news/3462609-oppenheimer-confident-on-gopro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462606\" data-ts=\"1557499135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMR\" target=\"_blank\">RMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462606-rmr-groupminus-9_6-q2-reflects-repositioning-efforts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RMR Group -9.6% as Q2 reflects repositioning efforts</a></h4><ul><li>RMR Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RMR' title='The RMR Group Inc.'>RMR</a>) <font color=\"red\">drops 9.6%</font> after<a href=\"https://seekingalpha.com/pr/17508050-rmr-group-inc-announces-second-quarter-fiscal-2019-results\" target=\"_blank\"> fiscal Q2 EPS </a>of 50 cents misses the average analyst estimate of 57 cents and compares with adjusted EPS of 54 cents in the year-ago quarter.</li><li>\"Our operating results this quarter reflect the repositioning efforts we\u2019ve helped facilitate at certain of our client companies over the last six months to strengthen their balance sheets and improve their operating results and future prospects,\" said President and CEO Adam Portnoy.</li><li>Q2 total revenue of $130.1M, up from $59.3M a year ago, missed the average analyst estimate by $11.1M.</li><li>Management and advisory services revenue for the quarter ended March 31, 2019 of $43.4M fell from $47.6M a year ago.</li></ul><ol><li>Management services revenue from managed equity REITS of $35.2M fell from $39.5M a year earlier</li><li>Management services revenue from managed operator of $6.14M fell from $6.34M a year earlier.</li></ol><ul><li>Q2 adjusted EBITDA of $24.7M fell from $28.3M a year ago and adjusted EBITDA margin of 54.1% narrowed from 56.5% a year ago.</li><li><a href=\"http://www.rmrgroup.com/\" target=\"_blank\">Conference call</a> at 1:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462440-rmr-group-misses-0_07-misses-revenue\" target=\"_blank\">RMR Group misses by $0.07, misses on revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462606\" data-linked=\"RMR Group -9.6% as Q2 reflects repositioning efforts\" data-tweet=\"$RMR - RMR Group -9.6% as Q2 reflects repositioning efforts https://seekingalpha.com/news/3462606-rmr-groupminus-9_6-q2-reflects-repositioning-efforts?source=tweet\" data-url=\"https://seekingalpha.com/news/3462606-rmr-groupminus-9_6-q2-reflects-repositioning-efforts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462601\" data-ts=\"1557498314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTHX\" target=\"_blank\">GTHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462601-investors-bullish-on-g1-therapeutics-after-q1-report-shares-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors bullish on G1 Therapeutics after Q1 report, shares up 22%</a></h4><ul><li>G1 Therapeutics (<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics, Inc.'>GTHX</a> <font color=\"green\">+22.1%</font>) is up on modestly higher volume in early trade following its <a href=\"https://seekingalpha.com/pr/17507316-g1-therapeutics-provides-first-quarter-2019-corporate-financial-update\" target=\"_blank\">Q1 report</a> released after the close yesterday. Investors appear to like its progress with trilaciclib and pipeline progress.</li><li>As it <a href=\"https://seekingalpha.com/news/3455652-g1-go-marketing-applications-trilaciclib\" target=\"_blank\">announced </a>a few weeks ago, it plans to file a marketing application in the U.S. in 2020 for trilaciclib for myelopreservation in small cell lung cancer. It expects to file an application in Europe after the U.S. submission.</li><li>Key future milestones for this year include a pre-NDA meeting with the FDA and reporting additional Phase 2 data on trilaciclib.</li><li>Additional potential catalysts are Phase 1 data on G1T48 in ER+ breast cancer in Q3, Phase 1b data on lerociclib/Tagrisso in non-small cell lung cancer in Q3 and additional Phase 1b data on lerociclib/Faslodex in ER+/HER2- breast cancer in Q4.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462173-g1-therapeutics-beats-0_08\" target=\"_blank\">G1 Therapeutics beats by $0.08</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462601\" data-linked=\"Investors bullish on G1 Therapeutics after Q1 report, shares up 22%\" data-tweet=\"$GTHX - Investors bullish on G1 Therapeutics after Q1 report, shares up 22% https://seekingalpha.com/news/3462601-investors-bullish-on-g1-therapeutics-after-q1-report-shares-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3462601-investors-bullish-on-g1-therapeutics-after-q1-report-shares-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462604\" data-ts=\"1557498221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAA\" target=\"_blank\">PRAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462604-pra-groupminus-2_8-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PRA Group -2.8% post Q1 results</a></h4><ul><li>PRA Group (<a href='https://seekingalpha.com/symbol/PRAA' title='PRA Group, Inc.'>PRAA</a> <font color=\"red\">-2.8%</font>) reports <a href=\"https://seekingalpha.com/pr/17507401-pra-group-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> revenue growth of 9.7% Y/Y to $245.9M.</li><li>Global cash collections of $461.2M, an increase of 8% Y/Y and on a currency adj. basis increased 11% Y/Y.</li><li>Cash Collection Source: Americas-Core $290.7M (+18.2% Y/Y); Americas-Insolvency $44.6M (-19.3% Y/Y); Europe-Core $116.9M (-0.9% Y/Y) &amp; Europe-Insolvency of $9M (+28.6% Y/Y).</li><li>Portfolio Purchase Source: Americas-Core $169.2M (+28.9% Y/Y); Americas-Insolvency $48.2M (+259% Y/Y); Europe-Core $94.2M (+423% Y/Y) &amp; Europe-Insolvency of $7.M (+29.6% Y/Y).</li><li>Cash collections on fully amortized pools were $12.1M and cash collections on nonaccrual pools were $3.7M.</li><li>The company invested $318.8M in finance receivables in Q1 &amp; had in place forward flow commitments of $351.5M.</li><li>Record estimated remaining collections of $6.26B and income recognized on finance receivables of $238.8M (+9.2% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462100-pra-group-misses-0_02-beats-revenue\" target=\"_blank\">PRA Group misses by $0.02, beats on revenue</a> (May. 09 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462604\" data-linked=\"PRA Group -2.8% post Q1 results\" data-tweet=\"$PRAA - PRA Group -2.8% post Q1 results https://seekingalpha.com/news/3462604-pra-groupminus-2_8-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3462604-pra-groupminus-2_8-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462602\" data-ts=\"1557497961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPTN\" target=\"_blank\">SPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462602-spartannash-lowers-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SpartanNash lowers guidance</a></h4><ul> <li>SpartanNash (<a href='https://seekingalpha.com/symbol/SPTN' title='SpartanNash Company'>SPTN</a> <font color='red'>-4.5%</font>) falls after the company's cut in guidance catches investors off guard.</li> <li>The food distributor expects full-year sales growth at a mid single-digit pace. EPS of $1.20 to $1.50 is anticipated vs. $1.70 to $1.80 prior view and $1.70 consensus. Adjusted EBITDA of $190M to $205M is seen vs. $210M to $220M prior and $215M consensus.</li> <li>Source: <a href=\"https://seekingalpha.com/pr/17507586-spartannash-announces-preliminary-first-quarter-2019-net-sales-earnings-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462602\" data-linked=\"SpartanNash lowers guidance\" data-tweet=\"$SPTN - SpartanNash lowers guidance https://seekingalpha.com/news/3462602-spartannash-lowers-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3462602-spartannash-lowers-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462592\" data-ts=\"1557496582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462592-boston-beer-aims-young-dogfish-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Beer aims young with Dogfish deal</a></h4><ul> <li>Boston Beer (NYSE:<a href='https://seekingalpha.com/symbol/SAM' title='The Boston Beer Company, Inc.'>SAM</a>) is <font color=\"green\">up 2.87%</font> as investors take in the company's acquisition of Dogfish Head.</li> <li>In its first read on the deal, Guggenheim points out the company's smart strategy of trying to bring in millennial and Generation Z drinkers with Samuel Adams customers showing grey hair. Even bearish-leaning Goldman Sachs concedes that the deal has \"strategic merit\" but is still cautious on SAM's valuation.</li> <li>Boston Beer pulled off today's deal with shares already up 42% YTD.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462353-boston-beer-drinks-dogfish-head-300m\" target=\"_blank\">Boston Beer drinks up Dogfish Head for $300M</a> (May 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462592\" data-linked=\"Boston Beer aims young with Dogfish deal\" data-tweet=\"$SAM - Boston Beer aims young with Dogfish deal https://seekingalpha.com/news/3462592-boston-beer-aims-young-dogfish-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3462592-boston-beer-aims-young-dogfish-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462585\" data-ts=\"1557495473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QURE\" target=\"_blank\">QURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462585-hemophilia-b-patients-responding-well-to-uniqure-gene-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hemophilia B patients responding well to uniQure gene therapy</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17508196-uniqure-announces-updated-clinical-data-phase-iib-study-amtminus-061-patients-hemophilia-b\" target=\"_blank\">Updated results</a> from an open-label <a href=\"https://clinicaltrials.gov/ct2/show/NCT02396342?lead=uniqure&amp;phase=1&amp;rank=4\" target=\"_blank\">Phase 2b clinical trial</a> evaluating uniQure's (<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) gene therapy candidate AMT-061 in patients with severe and moderately severe hemophilia B showed improvement since the last data <a href=\"https://seekingalpha.com/news/3431275-uniqures-gene-therapy-hemophilia-b-continues-show-treatment-effect-mid-stage-study-shares-2\" target=\"_blank\">readout</a> in February. The data are being presented today at the Hemostasis &amp; Thrombosis Research Society 2019 Scientific Symposium in New Orleans, LA.</li><li>After a single administration of AMT-061, two of three patients now have factor IX &#40;FIX&#41; activity in the normal range. Average FIX activity at month 6 post-treatment for the three subjects increased to 47% of normal (51%, 33% and 57% of normal, respectively). Patients #2 and #3 had previously failed to qualify for enrollment in another gene therapy study due to pre-existing neutralizing antibodies to a different AAV vector.</li><li>Through month 6, none of the three experienced serious adverse events, thrombotic (clotting) events or developed FIX antibodies.</li><li>A Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03569891?lead=uniqure&amp;phase=2&amp;rank=1\" target=\"_blank\">HOPE-B</a>, is currently recruiting patients with an estimated primary completion date of March 2020.</li><li>Shares are up <font color=\"green\">2%</font> in early trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462585\" data-linked=\"Hemophilia B patients responding well to uniQure gene therapy\" data-tweet=\"$QURE - Hemophilia B patients responding well to uniQure gene therapy https://seekingalpha.com/news/3462585-hemophilia-b-patients-responding-well-to-uniqure-gene-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3462585-hemophilia-b-patients-responding-well-to-uniqure-gene-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462584\" data-ts=\"1557495357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462584-momominus-6-on-one-month-post-suspension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo -6% on one-month post suspension</a></h4><ul><li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo Inc.'>MOMO</a>) drops 6.4% after <a href=\"https://seekingalpha.com/pr/17508313-momo-announces-recent-development\" target=\"_blank\">announcing</a> it will temporarily suspend newsfeed posts on its platform between May 11 and June 11.</li><li>The action follows directives from government regulatory officials.</li><li>Momo says it's evaluating how the suspension will impact the business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462584\" data-linked=\"Momo -6% on one-month post suspension\" data-tweet=\"$MOMO - Momo -6% on one-month post suspension https://seekingalpha.com/news/3462584-momominus-6-on-one-month-post-suspension?source=tweet\" data-url=\"https://seekingalpha.com/news/3462584-momominus-6-on-one-month-post-suspension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462581\" data-ts=\"1557495226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MESA\" target=\"_blank\">MESA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462581-mesa-air-gains-altitude-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mesa Air gains altitude after earnings</a></h4><ul> <li>Mesa Air (NASDAQ:<a href='https://seekingalpha.com/symbol/MESA' title='Mesa Air Group, Inc.'>MESA</a>) tracks higher despite missing estimates on both lines its <a href=\"https://seekingalpha.com/pr/17507870-mesa-air-group-announces-second-quarter-fiscal-year-2019-results\" target=\"_blank\">FQ2</a> report.</li> <li>The company says the sequential drop in EPS was primarily driven by the timing of heavy maintenance events.</li> <li>Block hours were up 14.5% Y/Y during the quarter to 112.3K. Block hours are seen rising to 115.2K in FQ3.</li> <li>Shares of Mesa are <font color=\"green\">up 1.40%</font> premarket to $9.47 vs. the 52-week trading range of $6.36 to $16.41.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462364-mesa-air-misses-0_06-misses-revenue\" target=\"_blank\">Mesa Air misses by $0.06, misses on revenue</a> (May 10)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3462581\" data-linked=\"Mesa Air gains altitude after earnings\" data-tweet=\"$MESA - Mesa Air gains altitude after earnings https://seekingalpha.com/news/3462581-mesa-air-gains-altitude-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3462581-mesa-air-gains-altitude-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462577\" data-ts=\"1557495004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462577-yelpminus-10_1-b-riley-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp -10.1% as B. Riley downgrades</a></h4><ul>   <li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp Inc.'>YELP</a>) is <font color=\"red\">down 10.1%</font> premarket after yesterday's postmarket <a href=\"https://seekingalpha.com/news/3462103-yelp-minus-5_7-percent-q1-profits-fall-short\" target=\"_blank\">earnings miss</a>, which also featured light guidance for Q2 revenues.</li>    <li>B. Riley downgraded shares to Neutral, noting that \"effective pricing is declining as traffic has increased and we are unsure of the bottom.\" The firm cut its price target to $42 from $50, implying 5.7% upside from yesterday's close.</li>    <li>Otherwise neutral Citi noted revenue growth, but \"the slowest growth for the company on record,\" and suggested the outlook was \"potentially at risk\" as it assumed meaningful improvement in customer adds and stabilizing ARPU. (h/t Bloomberg)</li>    <li><a href=\"https://seekingalpha.com/article/4262343-yelp-inc-yelp-ceo-jeremy-stoppelman-q1-2019-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462577\" data-linked=\"Yelp -10.1% as B. Riley downgrades\" data-tweet=\"$YELP - Yelp -10.1% as B. Riley downgrades https://seekingalpha.com/news/3462577-yelpminus-10_1-b-riley-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3462577-yelpminus-10_1-b-riley-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462575\" data-ts=\"1557494621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAG\" target=\"_blank\">PLAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462575-planet-greenplus-9-after-landing-chinese-tea-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Planet Green +9% after landing Chinese tea company</a></h4><ul> <li>Planet Green Holdings  (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) announces a share exchange agreement with wholly-owned subsidiary Shanghai Xunyang Internet Technology Co.</li><li>Under the terms of the agreement, the subsidiary will acquire all outstanding equity interests of Xianning Bozhuang Tea Products, a company that produces tea products and sells such products in China.</li><li>Planet Green will issue an aggregate of 1.08M shares of stock  to the sellers in exchange for the transfer of all of the equity interest of Xianning to the subsidiary.</li>  <li>PLAG  <font color=\"green\">+9.23%</font> premarket to  $4.85.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17508206-planet-green-enters-agreement-acquire-xianning-bozhuang-tea-products-co-ltd\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3462575\" data-linked=\"Planet Green +9% after landing Chinese tea company\" data-tweet=\"$PLAG - Planet Green +9% after landing Chinese tea company https://seekingalpha.com/news/3462575-planet-greenplus-9-after-landing-chinese-tea-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3462575-planet-greenplus-9-after-landing-chinese-tea-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462574\" data-ts=\"1557494597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462574-gogoplus-3_9-william-blair-upgrades-on-delta-tests\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo +3.9% as William Blair upgrades on Delta tests</a></h4><ul>   <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo Inc.'>GOGO</a>) is <font color=\"green\">up 3.9%</font> premarket after an upgrade to Outperform by William Blair coming out of the company's <a href=\"https://seekingalpha.com/news/3461651-gogo-reports-q1-beats-line-outlook\" target=\"_blank\">earnings report</a> yesterday and news that Delta Air Lines would start testing free Wi-Fi on Gogo-equipped planes.</li>    <li>Delta is Gogo's biggest customer (30% of revenue), and the move is \"a large vote of confidence not only for Gogo\u2019s technology, but also for its newfound financial stability,\" Louie DiPalma writes. Other airlines could follow suit and boost average revenue per account, he says. (h/t Bloomberg)</li>    <li><a href=\"https://seekingalpha.com/article/4262159-gogos-gogo-ceo-oakleigh-thorne-q1-2019-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3462574\" data-linked=\"Gogo +3.9% as William Blair upgrades on Delta tests\" data-tweet=\"$GOGO - Gogo +3.9% as William Blair upgrades on Delta tests https://seekingalpha.com/news/3462574-gogoplus-3_9-william-blair-upgrades-on-delta-tests?source=tweet\" data-url=\"https://seekingalpha.com/news/3462574-gogoplus-3_9-william-blair-upgrades-on-delta-tests\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462573\" data-ts=\"1557494557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462573-earnings-related-names-top-premarket-losers-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings-related names top premarket losers list</a></h4><ul><li>Puma Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color=\"red\">-35%</font> on <a href=\"https://seekingalpha.com/news/3462114-puma-biotechnology-eps-0_21\" target=\"_blank\">Q1 earnings</a>.</li><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"red\">-31%</font> on <a href=\"https://seekingalpha.com/news/3462007-transenterix-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"red\">-30%</font> on <a href=\"https://seekingalpha.com/news/3462011-verastem-misses-0_05-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-21%</font> on <a href=\"https://seekingalpha.com/news/3462025-aqua-metals-misses-0_13-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Halcon Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcón Resources Corporation'>HK</a>) <font color=\"red\">-18%</font> on <a href=\"https://seekingalpha.com/news/3462234-halcon-resources-beats-0_08-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>FibroGen (NASDAQ:<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen, Inc.'>FGEN</a>) <font color=\"red\">-17%</font> on <a href=\"https://seekingalpha.com/news/3462215-fibrogen-beats-0_13-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3462028-symantec-eps-line-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3462126-maxar-technologies-misses-0_39-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Nevro (NYSE:<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro Corp.'>NVRO</a>) <font color=\"red\">-13%</font> on <a href=\"https://seekingalpha.com/news/3462212-nevro-misses-0_77-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>ARCA (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a>) <font color=\"red\">-13%</font> ahead of capital raise.</li><li>Jumia Technologies (NYSE:<a href='https://seekingalpha.com/symbol/JMIA' title='Jumia Technologies AG'>JMIA</a>) <font color=\"red\">-12%</font>.</li><li>American Electric Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc'>AETI</a>) <font color=\"red\">-11%</font>.</li><li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo Inc.'>MOMO</a>) <font color=\"red\">-11%</font>.</li><li>Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color=\"red\">-10%</font>.</li><li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp Inc.'>YELP</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3462041-yelp-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Senseonics Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3462132-senseonics-misses-0_03-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3462397-quorum-health-misses-0_25-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"red\">-8%</font>.</li><li>Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"red\">-7%</font>.</li><li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3461983-wynn-resorts-beats-0_03-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462573\" data-linked=\"Earnings-related names top premarket losers list\" data-tweet=\"$PBYI $TRXC $VSTM - Earnings-related names top premarket losers list https://seekingalpha.com/news/3462573-earnings-related-names-top-premarket-losers-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3462573-earnings-related-names-top-premarket-losers-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462571\" data-ts=\"1557494282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462571-gpro-jd-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GPRO, JD among premarket gainers</a></h4><ul><li>Buckeye Partners, L.P. (NYSE:<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners, L.P.'>BPL</a>) <font color=\"green\">+27%</font> on <a href=\"https://seekingalpha.com/news/3462553-buckeye-partners-misses-0_09-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"green\">+22%</font> on <a href=\"https://seekingalpha.com/pr/17507595-cool-holdings-buy-simply-mac-gamestop-executes-expansion-plans\" target=\"_blank\">agreement</a> to purchase all of the outstanding capital stock of Simply Mac.</li><li>Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"green\">+17%</font> on <a href=\"https://seekingalpha.com/news/3462068-westport-innovations-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/news/3462023-guardant-health-beats-0_06-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Zillow Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/news/3462008-zillow-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/pr/17508206-planet-green-enters-agreement-acquire-xianning-bozhuang-tea-products-co-ltd\" target=\"_blank\">agreement</a> to acquire Xianning Bozhuang Tea Products.</li><li>Zillow Group (NASDAQ:<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3462008-zillow-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc.'>BTX</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3462191-biotime-eps-0_30\" target=\"_blank\">Q1 earnings</a>.</li><li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com, Inc.'>JD</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3462431-jd-com-beats-rmb1_40-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3462298-village-farms-international-beats-0_12-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>CarGurus (NASDAQ:<a href='https://seekingalpha.com/symbol/CARG' title='CarGurus, Inc.'>CARG</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3462053-cargurus-beats-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Dropbox (NASDAQ:<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox, Inc.'>DBX</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3461986-dropbox-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3462002-gopro-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics, Inc.'>ADMA</a>) <font color=\"green\">+5%</font> to <a href=\"https://seekingalpha.com/news/3462470-adma-bio-go-launch-bivigam-u-s-antibody-production-disorder\" target=\"_blank\">launch</a> Bivigam in U.S. for antibody production disorder.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462571\" data-linked=\"GPRO, JD among premarket gainers\" data-tweet=\"$BPL $AWSM $WPRT - GPRO, JD among premarket gainers https://seekingalpha.com/news/3462571-gpro-jd-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3462571-gpro-jd-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462569\" data-ts=\"1557494158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNA\" target=\"_blank\">MRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462569-moderna-up-1-premarket-on-early-stage-data-on-flu-vaccine-candidates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moderna up 1% premarket on early-stage data on flu vaccine candidates</a></h4><ul><li>Moderna (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a>) perks up <font color=\"green\">1%</font> premarket on light volume in reaction to the <a href=\"https://seekingalpha.com/pr/17508306-moderna-announces-publication-phase-1-data-mrna-vaccines-two-potential-pandemic-influenza\" target=\"_blank\">results </a>from two Phase 1 studies assessing its mRNA vaccines against H10N8 and H7N9 influenza viruses. The data were just published the journal <em>Vaccine</em>.</li><li>Both trials met the primary safety endpoints and the secondary immunogenicity endpoints. No vaccine-related serious adverse events were observed. The most frequent adverse event was injection site pain.</li><li>The company says future development will be contingent on government or grant funding.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462569\" data-linked=\"Moderna up 1% premarket on early-stage data on flu vaccine candidates\" data-tweet=\"$MRNA - Moderna up 1% premarket on early-stage data on flu vaccine candidates https://seekingalpha.com/news/3462569-moderna-up-1-premarket-on-early-stage-data-on-flu-vaccine-candidates?source=tweet\" data-url=\"https://seekingalpha.com/news/3462569-moderna-up-1-premarket-on-early-stage-data-on-flu-vaccine-candidates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462564\" data-ts=\"1557493523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPL\" target=\"_blank\">BPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462564-buckeye-partners-agrees-to-6_5b-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckeye Partners agrees to $6.5B buyout</a></h4><ul><li>Buckeye Partners (NYSE:<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners, L.P.'>BPL</a>) <font color=\"green\">surges 28%</font> to $41.44 in premarket trading after  agreeing to be bought by IFM Global Infrastructure Fund for $41.50 per common unit in cash.</li><li>Deal represents a 27.5% premium to Buckeye's closing unit price on May 9, 2019.</li><li>Deal has a $10.3B enterprise value and $6.5B equity value and adds to IFM's midstream energy infrastructure portfolio.</li><li>Expected to close in Q4 2019.</li><li><a href=\"https://www.globenewswire.com/Tracker?data=ZRqkLwapMt8bcFusY0xn90s3-vaK42WRJU_YqFhl3rqgxj8_Vu9zOZXDfWd8FlUfEx6a6i1WEqResz6-hw25tudOT4Fta2p0iQfU1xeGUSln748wSYm9lVODssaYTpHVeCCgzKp6RePuBWQQRXi7Bg==\" target=\"_blank\">Conference call </a>at 11:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462553-buckeye-partners-misses-0_09-misses-revenue\" target=\"_blank\">Buckeye Partners misses by $0.09, misses on revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462564\" data-linked=\"Buckeye Partners agrees to $6.5B buyout\" data-tweet=\"$BPL - Buckeye Partners agrees to $6.5B buyout https://seekingalpha.com/news/3462564-buckeye-partners-agrees-to-6_5b-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3462564-buckeye-partners-agrees-to-6_5b-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>151&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462563\" data-ts=\"1557493485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GH\" target=\"_blank\">GH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462563-guardant-health-up-16-premarket-on-q1-beat-guidance-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guardant Health up 16% premarket on Q1 beat, guidance raise</a></h4><ul><li>Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) is up <font color=\"green\">16% </font>premarket on light volume after posting better-than-expected <a href=\"https://seekingalpha.com/pr/17507344-guardant-health-reports-first-quarter-2019-financial-results-raises-2019-revenue-guidance\" target=\"_blank\">Q1 result</a>s after the close yesterday. Highlights:</li><li>Revenue was up 120% to $36.7M.</li><li>Clinical test volume was 9,521 (+31%). Tests for biopharmaceutical customers rose 61% to 3,762.</li><li>Net loss: ($21.4M); loss/share: ($0.30).</li><li>A prospective colorectal screening study in over 10K patients will be launched in H2.</li><li><strong>2019 guidance</strong>: Revenue: $145M - 150M from $130M - 135M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462023-guardant-health-beats-0_06-beats-revenue\" target=\"_blank\">Guardant Health beats by $0.06, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462563\" data-linked=\"Guardant Health up 16% premarket on Q1 beat, guidance raise\" data-tweet=\"$GH - Guardant Health up 16% premarket on Q1 beat, guidance raise https://seekingalpha.com/news/3462563-guardant-health-up-16-premarket-on-q1-beat-guidance-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3462563-guardant-health-up-16-premarket-on-q1-beat-guidance-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462556\" data-ts=\"1557492830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIO\" target=\"_blank\">ABIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462556-arca-bio-down-16-premarket-ahead-of-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arca bio down 16% premarket ahead of capital raise</a></h4><ul><li>Nano cap ARCA biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a>) slips <font color=\"red\">16%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17505429-arca-biopharma-announces-first-quarter-2019-financial-results-provides-corporate-update\" target=\"_blank\">Q1 report</a> released on Wednesday after the close.</li><li>Its cash and equivalents were $8.0M at quarter-end. The company stated that it will need to raise new capital to fund operations, develop Gencaro and consummate a partnership or other potential transactions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3461318-arca-biopharma-beats-0_12\" target=\"_blank\">ARCA biopharma beats by $0.12</a> (May 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462556\" data-linked=\"Arca bio down 16% premarket ahead of capital raise\" data-tweet=\"$ABIO - Arca bio down 16% premarket ahead of capital raise https://seekingalpha.com/news/3462556-arca-bio-down-16-premarket-ahead-of-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3462556-arca-bio-down-16-premarket-ahead-of-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462553\" data-ts=\"1557492730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPL\" target=\"_blank\">BPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462553-buckeye-partners-misses-0_09-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckeye Partners misses by $0.09, misses on revenue</a></h4><ul><li>Buckeye Partners (NYSE:<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners, L.P.'>BPL</a>): Q1 GAAP EPS of $0.52 <font color=\"red\">misses by $0.09</font>.</li><li>Revenue of $1.03B (-12.7% Y/Y) <font color=\"red\">misses by $100M</font>.</li><li>Shares <font color=\"green\">+26.6%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17508294-buckeye-partners-l-p-reports-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3462553\" data-linked=\"Buckeye Partners misses by $0.09, misses on revenue\" data-tweet=\"$BPL - Buckeye Partners misses by $0.09, misses on revenue https://seekingalpha.com/news/3462553-buckeye-partners-misses-0_09-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3462553-buckeye-partners-misses-0_09-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462548\" data-ts=\"1557492189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPH\" target=\"_blank\">REPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462548-recro-pharmaplus-4-on-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recro Pharma +4% on Q1 beat</a></h4><ul><li>Recro Pharma (<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) <a href=\"https://seekingalpha.com/pr/17508085-recro-pharma-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1 results</a>: Revenues: $25.1M (+28.7%).</li><li>Net Loss: ($2M) (+84.0%); Loss Per Share: ($0.10) (+84.6%); Quick Assets: $58M (+50.6%).</li><li><strong>Financial Guidance</strong>: Revenue: $85M - 87M; Non-GAAP EBITDA: $38M- 40M.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462442-recro-pharma-beats-revenue\" target=\"_blank\">Recro Pharma beats on revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462548\" data-linked=\"Recro Pharma +4% on Q1 beat\" data-tweet=\"$REPH - Recro Pharma +4% on Q1 beat https://seekingalpha.com/news/3462548-recro-pharmaplus-4-on-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3462548-recro-pharmaplus-4-on-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462547\" data-ts=\"1557492007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462547-cars-complus-1-after-earnings-strategic-review-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com +1% after earnings, strategic review update</a></h4><ul> <li>Cars.com (NYSE:<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a>) tracks higher after posting a mixed <a href=\"https://seekingalpha.com/pr/17508123-cars-com-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> report and reaffirming prior full-year revenue guidance of (~$628M to $675M vs. $649M consensus).</li> <li>Q1 metrics: Average monthly unique visitors +16% to 22.4M, traffic +175 to 132.5M visits, dealer customers flat 19,300 vs. 19,921 a year ago, direct monthly average revenue per dealer +3% to $2,102.</li> <li>In regard to the company's review of strategic alternatives, Cars.com says it is engaged with \"multiple parties.\" A timetable has not been set for the conclusion of the review and the company doesn't intend to comment further unless the board has approved a specific course of action.</li> <li>Shares of CARS are <font color=\"green\">up 0.91%</font> to $21.91 vs. a 52-week trading range of $19.74 to $32.94.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462547\" data-linked=\"Cars.com +1% after earnings, strategic review update\" data-tweet=\"$CARS - Cars.com +1% after earnings, strategic review update https://seekingalpha.com/news/3462547-cars-complus-1-after-earnings-strategic-review-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3462547-cars-complus-1-after-earnings-strategic-review-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462546\" data-ts=\"1557492004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSCT\" target=\"_blank\">FSCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462546-forescoutminus-13_8-on-downside-revenue-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forescout -13.8% on downside revenue outlook</a></h4><ul><li>Forescout (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>)<font color=\"red\"> -13.8%</font> after its Q1 beats and 27% Y/Y revenue growth were offset by the Q2 outlook that has downside revenue from $75.3M to $78.3M (consensus: $83M) and adjusted loss per share of $0.48 to $0.46 (consensus: -$0.24).</li><li><a href=\"https://seekingalpha.com/pr/17507407-forescout-technologies-reports-first-quarter-2019-financial-results\" target=\"_blank\">Press release.</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3462098-forescout-technologies-beats-0_03-beats-revenue\" target=\"_blank\">ForeScout Technologies beats by $0.03, beats on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462546\" data-linked=\"Forescout -13.8% on downside revenue outlook\" data-tweet=\"$FSCT - Forescout -13.8% on downside revenue outlook https://seekingalpha.com/news/3462546-forescoutminus-13_8-on-downside-revenue-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3462546-forescoutminus-13_8-on-downside-revenue-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462539\" data-ts=\"1557491608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462539-tariffs-slash-apple-eps-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tariffs could slash Apple EPS - Morgan Stanley</a></h4><ul><li>Apple's (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) China reliance could cause its EPS to drop by about 23% or $3 in FY20 in the worst case tariff scenario, says a Morgan Stanley team of analysts led by Katy Huberty.</li><li>Apple would have to raise the price of the iPhone XS by $160 to pass the costs along to the consumer, which could further hurt demand and stretch out the upgrade cycle.</li><li>Apple shares are <font color=\"red\">down 1.4%</font> pre-market to $197.84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462539\" data-linked=\"Tariffs could slash Apple EPS - Morgan Stanley\" data-tweet=\"$AAPL - Tariffs could slash Apple EPS - Morgan Stanley https://seekingalpha.com/news/3462539-tariffs-slash-apple-eps-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3462539-tariffs-slash-apple-eps-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>112&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462531\" data-ts=\"1557491219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GENE\" target=\"_blank\">GENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462531-genetic-tech-debuts-two-new-cancer-tests-shares-ahead-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genetic Tech debuts two new cancer tests; shares ahead 15% premarket</a></h4><ul><li>Thinly traded nano cap Genetic Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/GENE' title='Genetic Technologies Limited'>GENE</a>) is up <font color=\"green\">15% </font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17508214-genetic-technologies-limited-asx-code-gtg-nasdaq-ticker-gene-announces-successful-completion\" target=\"_blank\">announcement </a>of two new tests, one for assessing the risk of colorectal cancer cancer and the other for risk of breast cancer.</li><li>The company plans to launch the tests, called GeneType for Colorectal Cancer and GeneType for Breast Cancer, through a global network of distribution partners (it is working with TGen in the U.S.).</li></ul><div class=\"tiny-share-widget\" data-id=\"3462531\" data-linked=\"Genetic Tech debuts two new cancer tests; shares ahead 15% premarket\" data-tweet=\"$GENE - Genetic Tech debuts two new cancer tests; shares ahead 15% premarket https://seekingalpha.com/news/3462531-genetic-tech-debuts-two-new-cancer-tests-shares-ahead-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3462531-genetic-tech-debuts-two-new-cancer-tests-shares-ahead-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462529\" data-ts=\"1557491053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARG\" target=\"_blank\">CARG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462529-cargurusplus-8-after-strong-quarter-guidance-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarGurus +8% after strong quarter, guidance lift</a></h4><ul> <li>CarGurus (NASDAQ:<a href='https://seekingalpha.com/symbol/CARG' title='CarGurus, Inc.'>CARG</a>) <font color=\"green\">shoots up 7.63%</font> in premarket action after the company topped estimates on both lines of its Q1 report and upped its guidance.</li>  <li>Looking ahead, CarGurus expects full-year revenue of $569M to $578M vs. $554M to $566M prior view and $565M consensus. EPS of $0.39 to $0.43 is anticipated vs. $0.35 to $0.40 prior view and $0.39 consensus.</li><li>Citi and William Blair both have notes out in support of their bullish views on CarGurus, pointing to CARG's solid traffic trends despite concerns over a Google algorithm change.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462529\" data-linked=\"CarGurus +8% after strong quarter, guidance lift\" data-tweet=\"$CARG - CarGurus +8% after strong quarter, guidance lift https://seekingalpha.com/news/3462529-cargurusplus-8-after-strong-quarter-guidance-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3462529-cargurusplus-8-after-strong-quarter-guidance-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462527\" data-ts=\"1557490804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QGEN\" target=\"_blank\">QGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462527-qiagen-to-buy-back-fourth-tranche-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qiagen to buy back fourth tranche of shares</a></h4><ul><li>QIAGEN N.V. (NYSE:<a href='https://seekingalpha.com/symbol/QGEN' title='QIAGEN N.V.'>QGEN</a>) has <a href=\"https://seekingalpha.com/pr/17507932-qiagen-disclosure-according-article-5-section-1-6-eu-regulation-596-2014-article-2-section-1\" target=\"_blank\">initiated </a>the repurchase of the fourth tranche of 2M common shares announced on January 31. The transactions will be executed exclusively on the Frankfurt Stock Exchange.</li><li>Shares are down <font color=\"red\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462527\" data-linked=\"Qiagen to buy back fourth tranche of shares\" data-tweet=\"$QGEN - Qiagen to buy back fourth tranche of shares https://seekingalpha.com/news/3462527-qiagen-to-buy-back-fourth-tranche-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3462527-qiagen-to-buy-back-fourth-tranche-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462516\" data-ts=\"1557489929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462516-opko-up-4-premarket-frost-buys-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opko up 4% premarket as Frost buys in</a></h4><ul><li>OPKO Health (NASDAQ:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) is up <font color=\"green\">4%</font> premarket on light volume in apparent reaction to a round of insider buying, including CEO Philip Frost who purchased 285K shares yesterday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462516\" data-linked=\"Opko up 4% premarket as Frost buys in\" data-tweet=\"$OPK - Opko up 4% premarket as Frost buys in https://seekingalpha.com/news/3462516-opko-up-4-premarket-frost-buys-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3462516-opko-up-4-premarket-frost-buys-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462505\" data-ts=\"1557489325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCR\" target=\"_blank\">NVCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462505-novocure-up-2-premarket-on-proposed-medicare-coverage-of-optune\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novocure up 2% premarket on proposed Medicare coverage of Optune</a></h4><ul><li>Novocure (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure Limited'>NVCR</a>) is up <font color=\"green\">2% </font>premarket on light volume in reaction to <a href=\"https://seekingalpha.com/pr/17508008-medicare-issues-proposed-local-coverage-determination-provides-coverage-optune-newly\" target=\"_blank\">proposed Medicare coverage</a> of Optune (Tumor Treating Fields) for newly diagnosed glioblastoma.</li><li>The proposal is subject to a 45-day public comment period before implementation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462505\" data-linked=\"Novocure up 2% premarket on proposed Medicare coverage of Optune\" data-tweet=\"$NVCR - Novocure up 2% premarket on proposed Medicare coverage of Optune https://seekingalpha.com/news/3462505-novocure-up-2-premarket-on-proposed-medicare-coverage-of-optune?source=tweet\" data-url=\"https://seekingalpha.com/news/3462505-novocure-up-2-premarket-on-proposed-medicare-coverage-of-optune\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462502\" data-ts=\"1557488936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462502-colony-capital-closed-on-310m-of-commitments-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colony Capital closed on $310M of commitments in Q1</a></h4><ul><li>Colony Capital (NYSE:<a href='https://seekingalpha.com/symbol/CLNY' title='Colony Capital, Inc.'>CLNY</a>)<a href=\"https://seekingalpha.com/pr/17508058-colony-capital-announces-first-quarter-2019-financial-results\" target=\"_blank\"> Q1 core FFO </a>of $47.7M, or 9 cents per share.</li><li>Excluding net investment losses of $27.7M, core FFO would be $75.4M, or 15 cents per share; the net investment losses were comprised of $14.1M of losses on sale of and provision for loan losses on certain other equity and debt investments and $13.6M for its share of certain investment losses realized by Colony Credit Real Estate.</li><li>Consensus estimate is 13 cents.</li><li>Q1 total revenue of $632.9M, exceeding the consensus estimate of $627.5M, fell from $666.7M a year earlier.</li><li>Closed on commitments of $310M in third-party capital (including amounts related to affiliates).</li><li>Completed planned sale and/or monetization of $190M of assets, resulting in net proceeds of $93M.</li><li>Q1 healthcare comparable net operating income increased 2.7% Q/Q due to higher one-time expenses in Q4 and increased rental rates in Q1 in the senior housing operating portfolio.</li><li>Q1 light industrial same-store NOI increased 0.6% Q/Q primarily due to contractual rent escalations on in-place leases, offset by budgeted vacancy, and increased real estate tax and insurance expenses.</li><li>Q1 hospitality real estate NOI before FF&amp;E Reserve increased 2.4%, primarily due to an increase in ancillary revenue.</li><li><a href=\"https://edge.media-server.com/m6/p/xbajidyo\" target=\"_blank\">Conference call</a> at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462452-colony-capital-beats-revenue\" target=\"_blank\">Colony Capital beats on revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462502\" data-linked=\"Colony Capital closed on $310M of commitments in Q1\" data-tweet=\"$CLNY - Colony Capital closed on $310M of commitments in Q1 https://seekingalpha.com/news/3462502-colony-capital-closed-on-310m-of-commitments-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3462502-colony-capital-closed-on-310m-of-commitments-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462500\" data-ts=\"1557488658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVRO\" target=\"_blank\">NVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462500-nevro-down-15-premarket-on-q1-miss-soft-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nevro down 15% premarket on Q1 miss soft Q2 guidance</a></h4><ul><li>Nevro (NYSE:<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro Corp.'>NVRO</a>) is down <font color=\"red\">15%</font> premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17507489-nevro-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1 report</a> issued after the close yesterday. Highlights:</li><li>Total revenue was $82.1M, down 6%. U.S. revenue was $65.8M, down 7% primarily due to the company's efforts to \"diminish the impact\" of high volume orders.</li><li>Net loss: ($44.1M); loss/share: ($1.45).</li><li><strong>Q2 guidance</strong>: Revenue: $87M - 89M (below current consensus of $101.4M).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462212-nevro-misses-0_77-misses-revenue\" target=\"_blank\">Nevro misses by $0.77, misses on revenue</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462500\" data-linked=\"Nevro down 15% premarket on Q1 miss soft Q2 guidance\" data-tweet=\"$NVRO - Nevro down 15% premarket on Q1 miss soft Q2 guidance https://seekingalpha.com/news/3462500-nevro-down-15-premarket-on-q1-miss-soft-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3462500-nevro-down-15-premarket-on-q1-miss-soft-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462497\" data-ts=\"1557488537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462497-kandi-technologiesminus-2-after-joint-venture-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi Technologies -2% after joint venture loss</a></h4><ul> <li>Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) <a href=\"https://seekingalpha.com/pr/17508100-kandi-technologies-reports-first-quarter-2019-financial-results\" target=\"_blank\">reports</a> revenue soared 117% Y/Y and gross profit rose 114% to $3.1M, although a GAAP EPS loss was recorded for the quarter.</li> <li>CEO Hu Xiaoming explained the Kandi-Geely JV loss that impacted Kandi's bottom line.</li> <li>Xiaoming: \"The Chinese government's national subsidy policy adjustment during the first quarter coupled with the JV company's pending restructuring, which is taking place in order to maximize the JV company's ability to grow into a prominent company, has resulted in our modifying the JV company's business development plan with respect to its integration into Geely under Geely's management as a primary shareholder. This transition period has directly impacted production and sales, causing a loss for the JV company.\"</li> <li>Shares of Kandi are <font color=\"red\">down 1.96%</font> premarket to $5.00 vs. a 52-week trading range of $3.54 to $9.23.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462448-kandi-technologies-reports-q1-results\" target=\"_blank\">Kandi Technologies reports Q1 results</a> (May 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462497\" data-linked=\"Kandi Technologies -2% after joint venture loss\" data-tweet=\"$KNDI - Kandi Technologies -2% after joint venture loss https://seekingalpha.com/news/3462497-kandi-technologiesminus-2-after-joint-venture-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3462497-kandi-technologiesminus-2-after-joint-venture-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462489\" data-ts=\"1557487999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462489-3d-systemsplus-3-on-valuation-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems +3% on valuation upgrade</a></h4><ul><li>JPMorgan upgrades 3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corporation'>DDD</a>) from Underweight to Neutral.</li><li>Analyst Paul Coster cites improved valuation thanks to the post-earnings sell-off, which offsets the continuing volatility of the stock.</li><li>Coster says 3D's Q2 \"may remain pressured owing to tough comps, and product mix shift to lower priced printers coupled with slowing materials sales\" will ding margins.</li><li>3D shares are <font color=\"green\">up 3.2%</font> pre-market to $8.67. Shares are <font color=\"red\">down 21%</font> this week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3460346-3d-systems-minus-11_6-percent-revenue-miss-demand-weakness\" target=\"_blank\">3D Systems -11.6% on revenue miss, demand weakness</a> (May 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462489\" data-linked=\"3D Systems +3% on valuation upgrade\" data-tweet=\"$DDD - 3D Systems +3% on valuation upgrade https://seekingalpha.com/news/3462489-3d-systemsplus-3-on-valuation-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3462489-3d-systemsplus-3-on-valuation-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462488\" data-ts=\"1557487962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONO\" target=\"_blank\">SONO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462488-sonosplus-5-after-focus-on-efficiency-pays-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonos +5% after focus on efficiency pays off</a></h4><ul> <li>Sonos (NASDAQ:<a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a>) <font color=\"green\">jumps 4.58%</font> premarket after posting a narrower-than-anticipated <a href=\"https://seekingalpha.com/pr/17507473-sonos-announces-record-second-fiscal-quarter-revenue\" target=\"_blank\">FQ2</a> loss on revenue growth of 13%.</li> <li>Revenue growth in the home theater speakers business offset a drop in wireless speakers sales.</li> <li>Gross margin was down 60 bps compared to a year ago to 43.0% amid a significant mix shift to the new products such as Beam, AMP and Sonos One.</li><li>\"Our operating expenses were 1.5% lower on a year-over-year basis as we continue to increase efficiency in sales and marketing, which declined by 17% year-over-year, while still delivering double-digit revenue growth in the quarter,\" notes the company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462022-sonos-beats-0_13-misses-revenue\" target=\"_blank\">Sonos beats by $0.13, misses on revenue</a> (May 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462488\" data-linked=\"Sonos +5% after focus on efficiency pays off\" data-tweet=\"$SONO - Sonos +5% after focus on efficiency pays off https://seekingalpha.com/news/3462488-sonosplus-5-after-focus-on-efficiency-pays-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3462488-sonosplus-5-after-focus-on-efficiency-pays-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462483\" data-ts=\"1557487566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462483-jd-complus-10-on-beats-tencent-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com +10% on beats, Tencent agreement</a></h4><ul><li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com, Inc.'>JD</a>) <font color=\"green\">+9.9%</font> reports Q1 beats with 21% Y/Y revenue growth. In-line Q2 guidance has revenue of RMB 145-150B vs. RMB 145.53B.</li><li>Q1 net service revenue was up 44% Y/Y to $1.9B. Net product revenue was up 19% in the period to $16.2B. Cost of revenue grew 20% to $15.3B.</li><li>Non-GAAP operating margin was up from 0.8% to 1.6%.</li><li>Annual active customer accounts increased from 305.3M to 310.5M. Quarterly active accounts were up 15% Y/Y.</li><li>JD had over 220K merchants and 179K full-time employees at the end of the quarter.</li><li>JD ended the quarter with $6.1B in cash and equivalents.</li><li>Tencent agreement: JD renews its agreement with Tencent for a three-year period starting May 27. Tencent will offer Weixin access points for traffic support and the companies will continue to collab on projects. The cooperation will amount to $800M and Tencent will issue about $250M in Class A shares over the three years.</li><li>Earnings call starts at 7:30 with a webcast <a href=\"https://www.globenewswire.com/Tracker?data=FZyiyH8bNCNxezaeBE1W4KIfvYHHltxWrzhCYqMrH-6rkSok1XJY9M1BmCiRVA5Wqybyh4YBzAVBhceFWwcT9g==\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17508031-jd-com-announces-first-quarter-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462431-jd-com-beats-rmb1_40-beats-revenue\" target=\"_blank\">JD.com beats by RMB1.40, beats on revenue</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3462483\" data-linked=\"JD.com +10% on beats, Tencent agreement\" data-tweet=\"$JD $TCTZF $TCEHY - JD.com +10% on beats, Tencent agreement https://seekingalpha.com/news/3462483-jd-complus-10-on-beats-tencent-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3462483-jd-complus-10-on-beats-tencent-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462470\" data-ts=\"1557487174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMA\" target=\"_blank\">ADMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462470-adma-bio-on-go-to-launch-bivigam-in-u-s-for-antibody-production-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADMA Bio on go to launch Bivigam in U.S. for antibody production disorder</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17508034-fda-approves-prior-approval-supplement-bivigam\" target=\"_blank\">approved </a>ADMA Biologics' (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics, Inc.'>ADMA</a>) Prior Approval Supplement for BIVIGAM (immune globulin intravenous (human), 10% liquid) for its optimized intravenous immune globulin manufacturing process.</li><li>The agency's sign-off enables the company to commence marketing the product in the U.S. for an inherited antibody production disorder called <a href=\"https://www.uptodate.com/contents/primary-humoral-immunodeficiencies-an-overview\" target=\"_blank\">primary humoral immunodeficiency</a>.</li><li>Commercial launch will begin shortly.</li><li>Shares, currently halted, will resume trading at 7:30 am ET.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">10%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3462470\" data-linked=\"ADMA Bio on go to launch Bivigam in U.S. for antibody production disorder\" data-tweet=\"$ADMA - ADMA Bio on go to launch Bivigam in U.S. for antibody production disorder https://seekingalpha.com/news/3462470-adma-bio-on-go-to-launch-bivigam-in-u-s-for-antibody-production-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3462470-adma-bio-on-go-to-launch-bivigam-in-u-s-for-antibody-production-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462463\" data-ts=\"1557486920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELY\" target=\"_blank\">ELY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462463-callaway-golf-gains-after-earnings-smasher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callaway Golf gains after earnings smasher</a></h4><ul> <li>Callaway Golf (NYSE:<a href='https://seekingalpha.com/symbol/ELY' title='Callaway Golf Company'>ELY</a>) is <font color=\"green\">up 2.0%</font> in premarket trading after the company's strong <a href=\"https://seekingalpha.com/pr/17507566-callaway-golf-company-announces-record-first-quarter-net-sales-raises-full-year-earnings-per\" target=\"_blank\">Q1</a> results sail past consensus estimates.</li> <li>Revenue was up 28% during the quarter on solid growth across major product categories. The addition of the Jack Wolfskin business also factored in against last year's comparable.</li> <li>Adjusted EBITDA came in at $93M vs. $82M consensus.</li> <li>Looking ahead, Callaway expects full-year sales of $1.67B to $1.70B vs. $1.68B consensus and EPS of $0.96 to $1.06 vs. $0.93 to $1.03 prior and $0.98 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462081-callaway-golf-beats-0_15-beats-revenue\" target=\"_blank\">Callaway Golf beats by $0.15, beats on revenue</a> (May 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3462463\" data-linked=\"Callaway Golf gains after earnings smasher\" data-tweet=\"$ELY - Callaway Golf gains after earnings smasher https://seekingalpha.com/news/3462463-callaway-golf-gains-after-earnings-smasher?source=tweet\" data-url=\"https://seekingalpha.com/news/3462463-callaway-golf-gains-after-earnings-smasher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3462437\" data-ts=\"1557486125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIAB\" target=\"_blank\">VIAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3462437-viacom-beats-0_14-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom beats by $0.14, misses on revenue</a></h4><ul><li>Viacom (NASDAQ:<a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>): Q2 Non-GAAP EPS of $0.95 <font color=\"green\">beats by $0.14</font>; GAAP EPS of $0.90 <font color=\"green\">beats by $0.10</font>.</li><li>Revenue of $2.96B (-6.0% Y/Y) <font color=\"red\">misses by $100M</font>.</li><li>Shares <font color=\"green\">+4.07%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17508052-viacom-reports-second-quarter-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3462437\" data-linked=\"Viacom beats by $0.14, misses on revenue\" data-tweet=\"$VIAB $VIA - Viacom beats by $0.14, misses on revenue https://seekingalpha.com/news/3462437-viacom-beats-0_14-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3462437-viacom-beats-0_14-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}